,DOWNLOAD NAME,DOWNLOAD URL,BIOSAMPLE NAME,CONDITION,BIOFLUID,RNA SOURCE,RNA ISOLATION KIT,ANATOMICAL LOCATION,CELL CULTURE SOURCE,PROFILING ASSAY,SPECIES,MEETS ERCC QC STANDARDS?,TRANSCRIPTOME READS,REFERENCE GENOME READS,TRANSCRIPTOME GENOME RATIO,BIOSAMPLE ACCESSION ID,RELATED DATASET ACCESSION ID,FASTQ IDENTIFIER,Sample Name,ApoE,expired_age,DiseaseDuration,PMI,DLB,VAD,PSP,PlaqueF,PlaqueT,PlaqueP,PlaqueH,PlaqueE,PlaqueTotal,Plaque density,TangleF,TangleT,TangleP,TangleH,TangleE,TangleTotal,Braak score,NIA-R,LB Stage,sn_depigmentation,Run,sex
0,sample_SAMPLE_0852_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0852_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0852_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0852 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,6883461,6923368,0.994236,EXR-KJENS10CSF0852-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0852_CONTROL_CSF_fastq,08_52_CSF,3/3,94,8.0,2.5,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,1.0,3.0,2.0,3.0,3.0,12.0,IV,criteria not met,No Lewy bodies,none,SRR1568567,male
1,sample_SAMPLE_9926_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9926_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9926_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9926 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2904451,2953867,0.983271,EXR-KJENS10SER9926-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9926_PD_SER_fastq,99_26_SER,3/3,79,1.0,6.0,no,no,no,0.0,1.75,1.0,0.0,0.0,2.75,sparse,0.0,0.75,0.0,1.5,1.0,3.25,II,criteria not met,Limbic type,severe,SRR1568730,female
2,sample_SAMPLE_9722_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9722_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9722_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9722 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,12132405,12781881,0.949188,EXR-KJENS10SER9722-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9722_AD_SER_fastq,97_22_SER,3/4,81,7.0,2.5,no,no,no,2.5,2.5,2.0,2.5,2.0,11.5,frequent,1.6,2.5,1.0,3.0,3.0,11.1,V,high,No Lewy bodies,mild,SRR1568666,female
3,sample_SAMPLE_0644_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0644_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0644_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0644 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,5560256,5622788,0.988879,EXR-KJENS10CSF0644-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0644_PD_CSF_fastq,06_44_CSF,3/3,79,4.0,2.5,no,no,no,1.5,2.0,1.5,1.0,1.5,7.5,moderate,0.0,0.5,0.0,1.0,1.5,3.0,II,low,Neocortical type,severe,SRR1568510,male
4,sample_SAMPLE_0662_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0662_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0662_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0662 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,12131859,12219540,0.992825,EXR-KJENS10CSF0662-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0662_PD_CSF_fastq,06_62_CSF,3/3,82,18.0,4.16,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.5,0.0,3.0,3.0,6.5,III,criteria not met,Limbic type,severe,SRR1568518,female
5,sample_SAMPLE_0720_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0720_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0720_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0720 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1806347,2183522,0.827263,EXR-KJENS10SER0720-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0720_AD_SER_fastq,07_20_SER,3/3,57,10.0,2.16,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,No Lewy bodies,mild,SRR1568530,female
6,sample_SAMPLE_9811_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9811_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9811_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9811 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1430536,1445399,0.989717,EXR-KJENS10CSF9811-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9811_PD_CSF_fastq,98_11_CSF,3/3,76,2.0,5.16,no,no,yes,1.0,1.5,1.5,0.0,2.0,6.0,zero,0.0,0.75,0.0,2.0,2.0,4.75,III,not AD,Brainstem predominant type,moderate,SRR1568689,male
7,sample_SAMPLE_0950_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0950_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0950_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0950 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,383151,552392,0.693622,EXR-KJENS10SER0950-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0950_CONTROL_SER_fastq,09_50_SER,3/3,53,,3.66,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,0.5,0.5,1.0,I,criteria not met,No Lewy bodies,none,SRR1568603,male
8,sample_SAMPLE_0957_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0957_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0957_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0957 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,2306534,2348748,0.982027,EXR-KJENS10CSF0957-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0957_CONTROL_CSF_fastq,09_57_CSF,2/2,80,,3.5,no,no,no,0.0,1.5,0.5,0.0,2.5,4.5,sparse,0.0,0.5,0.0,2.0,2.5,5.0,III,criteria not met,No Lewy bodies,none,SRR1568605,male
9,sample_SAMPLE_0915_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0915_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0915_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0915 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3263416,3320847,0.982706,EXR-KJENS10CSF0915-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0915_PD_CSF_fastq,09_15_CSF,3/3,84,17.0,3.75,no,no,no,3.0,3.0,3.0,2.0,3.0,14.0,frequent,0.0,0.5,0.5,3.0,3.0,7.0,IV,intermediate,Neocortical type,severe,SRR1568587,male
10,sample_SAMPLE_0201_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0201_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0201_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0201 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,FAIL,80270,87748,0.914779,EXR-KJENS10SER0201-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0201_CONTROL_SER_fastq,02_01_SER,3/3,88,1.0,3.0,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.5,0.0,2.0,2.0,4.5,IV,criteria not met,No Lewy bodies,mild,SRR1568392,female
11,sample_SAMPLE_0201_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0201_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0201_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0201 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,FAIL,80270,87748,0.914779,EXR-KJENS10SER0201-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0201_CONTROL_SER_fastq,02_01_SER,3/4,88,1.0,2.0,no,no,no,1.5,1.5,2.0,0.0,1.25,6.25,moderate,0.0,0.0,0.0,0.5,2.0,2.5,III,criteria not met,No Lewy bodies,none,SRR1568392,female
12,sample_SAMPLE_9914_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9914_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_9914_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9914 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,621743,955445,0.650737,EXR-KJENS10SER9914-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9914_CONTROL_SER_fastq,99_14_SER,3/3,86,,2.5,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.5,0.0,1.0,2.0,3.5,II,criteria not met,No Lewy bodies,none,SRR1568721,male
13,sample_SAMPLE_0027_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0027_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0027_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0027 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,FAIL,833099,3460122,0.240772,EXR-KJENS10SER0027-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0027_PD_SER_fastq,00_27_SER,3/4,73,29.0,2.16,no,no,no,0.25,0.5,0.5,0.0,0.0,1.25,sparse,0.0,0.0,0.0,2.0,1.5,3.5,III,low,Neocortical type,severe,SRR1568365,female
14,sample_SAMPLE_9737_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9737_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_9737_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9737 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,3542039,3633028,0.974955,EXR-KJENS10SER9737-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9737_CONTROL_SER_fastq,97_37_SER,3/4,83,,3.16,no,no,no,0.0,0.5,0.5,0.0,0.0,1.0,zero,0.0,0.0,0.0,0.0,1.0,1.0,I,criteria not met,No Lewy bodies,none,SRR1568671,male
15,sample_SAMPLE_9751_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9751_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9751_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9751 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1040224,1048770,0.991851,EXR-KJENS10CSF9751-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9751_CONTROL_CSF_fastq,97_51_CSF,3/3,84,,3.0,no,no,no,2.8,2.3,2.5,0.5,2.5,10.6,frequent,0.0,1.0,0.0,1.0,2.5,4.5,III,criteria not met,No Lewy bodies,moderate,SRR1568681,male
16,sample_SAMPLE_0623_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0623_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0623_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0623 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,4719248,4771701,0.989007,EXR-KJENS10CSF0623-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0623_PD_CSF_fastq,06_23_CSF,3/3,77,23.0,4.0,no,no,no,2.5,2.5,2.0,0.0,2.0,9.0,frequent,1.0,1.0,1.0,3.0,3.0,9.0,IV,intermediate,Limbic type,severe,SRR1568503,female
17,sample_SAMPLE_0757_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0757_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0757_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0757 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3010513,3028354,0.994109,EXR-KJENS10CSF0757-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0757_AD_CSF_fastq,07_57_CSF,,91,10.0,2.5,no,no,no,3.0,3.0,3.0,1.0,3.0,13.0,frequent,0.5,3.0,1.5,3.0,3.0,11.0,IV,intermediate,No Lewy bodies,mild,SRR1568540,female
18,sample_SAMPLE_0507_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0507_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0507_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0507 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1591692,1634444,0.973843,EXR-KJENS10CSF0507-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0507_PD_CSF_fastq,05_07_CSF,3/4,81,4.0,2.0,no,no,yes,3.0,2.75,3.0,1.5,2.75,13.0,moderate,0.0,1.0,0.0,2.0,2.75,5.75,IV,intermediate,Limbic type,severe,SRR1568471,female
19,sample_SAMPLE_0330_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0330_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0330_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0330 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,6205635,6280702,0.988048,EXR-KJENS10CSF0330-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0330_AD_CSF_fastq,03_30_CSF,3/4,60,5.0,2.0,no,no,no,3.0,3.0,3.0,2.75,3.0,14.75,frequent,3.0,3.0,3.0,2.75,3.0,14.75,VI,high,No Lewy bodies,severe,SRR1568432,female
20,sample_SAMPLE_9745_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9745_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_9745_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9745 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1446775,2261666,0.639694,EXR-KJENS10SER9745-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9745_CONTROL_SER_fastq,97_45_SER,3/3,79,,3.0,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,1.0,0.5,1.0,1.5,4.0,I,criteria not met,No Lewy bodies,none,SRR1568676,male
21,sample_SAMPLE_9964_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9964_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9964_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9964 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,9482227,9613777,0.986317,EXR-KJENS10CSF9964-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9964_AD_CSF_fastq,99_64_CSF,3/4,79,10.0,1.5,no,no,no,3.0,3.0,3.0,2.5,2.5,14.0,frequent,2.66,3.0,3.0,3.0,3.0,14.66,VI,high,No Lewy bodies,severe,SRR1568755,female
22,sample_SAMPLE_0144_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0144_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0144_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0144 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2339113,2699088,0.866631,EXR-KJENS10SER0144-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0144_CONTROL_SER_fastq,01_44_SER,3/3,78,,2.83,no,no,no,2.33,1.75,2.0,1.0,1.75,8.83,moderate,0.0,0.0,0.0,1.5,2.75,4.25,III,criteria not met,No Lewy bodies,moderate,SRR1568385,female
23,sample_SAMPLE_0516_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0516_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0516_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0516 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3892154,4027710,0.966344,EXR-KJENS10CSF0516-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0516_CONTROL_CSF_fastq,05_16_CSF,3/3,82,,3.0,no,no,no,0.75,1.5,0.25,0.0,1.5,4.0,sparse,0.0,1.0,0.0,1.0,1.0,3.0,III,criteria not met,No Lewy bodies,mild,SRR1568476,male
24,sample_SAMPLE_0233_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0233_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0233_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0233 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,4016884,4145876,0.968887,EXR-KJENS10CSF0233-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0233_CONTROL_CSF_fastq,02_33_CSF,3/3,85,,2.25,no,no,no,1.5,2.0,2.0,0.0,2.75,8.25,moderate,0.0,1.0,0.0,1.5,2.5,5.0,III,criteria not met,No Lewy bodies,none,SRR1568404,male
25,sample_SAMPLE_9724_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9724_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9724_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9724 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,4873034,5075276,0.960152,EXR-KJENS10CSF9724-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9724_AD_CSF_fastq,97_24_CSF,3/4,85,1.0,2.66,no,no,no,2.8,3.0,3.0,1.5,3.0,13.3,frequent,1.8,3.0,2.0,3.0,3.0,12.8,V,high,No Lewy bodies,none,SRR1568667,female
26,sample_SAMPLE_0734_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0734_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0734_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0734 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1932548,1965526,0.983222,EXR-KJENS10CSF0734-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0734_AD_CSF_fastq,07_34_CSF,3/3,86,,2.5,no,no,no,3.0,3.0,3.0,1.5,1.0,11.5,frequent,3.0,3.0,0.0,3.0,3.0,12.0,IV,intermediate,No Lewy bodies,none,SRR1568533,female
27,sample_SAMPLE_0438_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0438_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0438_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0438 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,7435200,7518459,0.988926,EXR-KJENS10CSF0438-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0438_CONTROL_CSF_fastq,04_38_CSF,2/2,83,,4.83,no,no,no,2.5,2.5,3.0,0.5,1.5,10.0,moderate,0.0,0.0,0.0,0.5,1.0,1.5,II,criteria not met,No Lewy bodies,none,SRR1568463,female
28,sample_SAMPLE_0127_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0127_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0127_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0127 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,5923134,6033943,0.981636,EXR-KJENS10CSF0127-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0127_PD_CSF_fastq,01_27_CSF,2/4,72,9.0,3.0,no,no,no,2.0,1.75,2.5,0.0,0.75,7.0,moderate,0.0,0.0,0.0,0.25,0.25,0.5,I,intermediate,Limbic type,severe,SRR1568376,male
29,sample_SAMPLE_0882_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0882_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0882_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0882 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,7726150,7810004,0.989263,EXR-KJENS10SER0882-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0882_AD_SER_fastq,08_82_SER,3/3,86,4.0,2.75,no,no,no,0.5,2.5,2.5,1.0,2.0,8.5,frequent,0.0,0.0,0.0,0.0,1.5,1.5,II,low,No Lewy bodies,none,SRR1568580,male
30,sample_SAMPLE_9748_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9748_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9748_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9748 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,5542334,5966072,0.928975,EXR-KJENS10SER9748-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9748_AD_SER_fastq,97_48_SER,3/4,90,12.0,3.5,no,no,no,2.3,3.0,3.0,2.5,2.5,13.3,frequent,2.0,3.0,3.0,3.0,3.0,14.0,VI,high,LB pathology unspecified or not further assessed,severe,SRR1568678,female
31,sample_SAMPLE_9910_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9910_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9910_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9910 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1064383,1534436,0.693664,EXR-KJENS10CSF9910-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9910_AD_CSF_fastq,99_10_CSF,3/4,74,7.0,2.0,no,no,no,2.6,3.0,3.0,2.5,2.5,13.6,frequent,3.0,3.0,3.0,3.0,3.0,15.0,V,high,No Lewy bodies,moderate,SRR1568718,female
32,sample_SAMPLE_9952_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9952_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9952_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9952 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3051969,3079164,0.991168,EXR-KJENS10CSF9952-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9952_AD_CSF_fastq,99_52_CSF,3/3,89,9.0,4.0,no,no,no,3.0,2.0,3.0,1.0,1.75,10.75,moderate,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,LB pathology unspecified or not further assessed,moderate,SRR1568747,female
33,sample_SAMPLE_0119_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0119_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0119_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0119 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,10772413,10976033,0.981449,EXR-KJENS10CSF0119-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0119_PD_CSF_fastq,01_19_CSF,2/3,87,18.0,2.66,no,no,yes,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,2.5,3.0,5.5,IV,not AD,Limbic type,severe,SRR1568372,female
34,sample_SAMPLE_9818_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9818_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9818_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9818 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1122849,1171777,0.958245,EXR-KJENS10CSF9818-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9818_AD_CSF_fastq,98_18_CSF,3/3,91,4.0,2.16,no,no,no,2.5,2.5,3.0,1.5,0.0,9.5,moderate,0.0,0.0,0.0,1.5,2.5,4.0,III,intermediate,No Lewy bodies,mild,SRR1568693,female
35,sample_SAMPLE_9622_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9622_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_9622_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9622 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,430634,646718,0.665876,EXR-KJENS10SER9622-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9622_CONTROL_SER_fastq,96_22_SER,3/3,94,,2.0,no,no,no,1.3,2.0,1.0,0.0,1.0,5.3,sparse,0.0,1.0,0.0,1.0,2.0,4.0,II,criteria not met,No Lewy bodies,none,SRR1568646,male
36,sample_SAMPLE_9611_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9611_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9611_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9611 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,FAIL,492609,1593828,0.309073,EXR-KJENS10SER9611-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9611_AD_SER_fastq,96_11_SER,3/3,83,6.0,2.83,no,no,no,3.0,3.0,3.0,2.0,2.0,13.0,frequent,1.3,2.0,2.5,3.0,3.0,11.8,VI,high,,,SRR1568641,male
37,sample_SAMPLE_0552_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0552_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0552_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0552 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,6613314,6634610,0.99679,EXR-KJENS10CSF0552-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0552_AD_CSF_fastq,05_52_CSF,3/3,70,4.0,2.66,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,No Lewy bodies,none,SRR1568489,female
38,sample_SAMPLE_9823_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9823_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_9823_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9823 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,469524,503706,0.932139,EXR-KJENS10SER9823-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9823_CONTROL_SER_fastq,98_23_SER,3/3,68,,2.0,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,1.0,0.0,0.5,1.0,2.5,I,criteria not met,No Lewy bodies,none,SRR1568699,male
39,sample_SAMPLE_9943_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9943_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9943_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9943 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3192576,3225774,0.989709,EXR-KJENS10CSF9943-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9943_AD_CSF_fastq,99_43_CSF,3/4,80,10.0,3.25,no,no,no,3.0,3.0,3.0,2.0,2.5,13.5,frequent,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,No Lewy bodies,none,SRR1568740,male
40,sample_SAMPLE_0330_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0330_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0330_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0330 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,3540066,4072019,0.869364,EXR-KJENS10SER0330-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0330_AD_SER_fastq,03_30_SER,3/4,60,5.0,2.0,no,no,no,3.0,3.0,3.0,2.75,3.0,14.75,frequent,3.0,3.0,3.0,2.75,3.0,14.75,VI,high,No Lewy bodies,severe,SRR1568433,female
41,sample_SAMPLE_1004_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_1004_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_1004_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,1004 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1573595,1589791,0.989812,EXR-KJENS10CSF1004-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_1004_PD_CSF_fastq,10_04_CSF,3/3,81,,3.55,no,no,no,3.0,3.0,3.0,2.0,2.5,13.5,frequent,0.5,1.0,0.5,2.0,3.0,7.0,III,intermediate,Neocortical type,severe,SRR1568607,male
42,sample_SAMPLE_0116_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0116_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0116_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0116 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,4526222,4682832,0.966557,EXR-KJENS10CSF0116-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0116_AD_CSF_fastq,01_16_CSF,3/4,87,12.0,3.0,no,no,no,3.0,3.0,3.0,2.0,2.25,13.25,frequent,2.5,2.75,1.0,3.0,3.0,12.25,V,high,No Lewy bodies,mild,SRR1568368,male
43,sample_SAMPLE_0914_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0914_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0914_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0914 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1230648,1246591,0.987211,EXR-KJENS10CSF0914-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0914_AD_CSF_fastq,09_14_CSF,3/3,89,9.0,2.75,no,no,no,3.0,2.5,1.5,0.5,1.0,8.5,frequent,0.0,1.0,0.0,3.0,3.0,7.0,IV,intermediate,No Lewy bodies,none,SRR1568585,female
44,sample_SAMPLE_9540_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9540_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_9540_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9540 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,644723,1175442,0.548494,EXR-KJENS10SER9540-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9540_CONTROL_SER_fastq,95_40_SER,3/3,74,,2.5,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.5,1.0,0.0,1.0,1.0,3.5,II,criteria not met,No Lewy bodies,none,SRR1568636,male
45,sample_SAMPLE_9928_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9928_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9928_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9928 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1993496,2047682,0.973538,EXR-KJENS10CSF9928-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9928_AD_CSF_fastq,99_28_CSF,3/4,80,3.0,3.0,no,no,no,2.5,2.5,3.0,3.0,3.0,14.0,moderate,0.0,0.5,0.0,3.0,3.0,6.5,IV,intermediate,No Lewy bodies,moderate,SRR1568733,male
46,sample_SAMPLE_0430_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0430_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0430_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0430 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3202097,3247739,0.985947,EXR-KJENS10CSF0430-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0430_CONTROL_CSF_fastq,04_30_CSF,2/3,78,,3.75,no,no,no,1.5,2.5,2.5,1.5,2.0,10.0,moderate,1.0,3.0,3.0,2.25,3.0,12.25,IV,criteria not met,No Lewy bodies,none,SRR1568459,female
47,sample_SAMPLE_0644_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0644_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0644_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0644 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1411489,1596978,0.88385,EXR-KJENS10SER0644-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0644_PD_SER_fastq,06_44_SER,3/3,79,4.0,2.5,no,no,no,1.5,2.0,1.5,1.0,1.5,7.5,moderate,0.0,0.5,0.0,1.0,1.5,3.0,II,low,Neocortical type,severe,SRR1568511,male
48,sample_SAMPLE_0936_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0936_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0936_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0936 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,3125009,3146174,0.993273,EXR-KJENS10SER0936-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0936_PD_SER_fastq,09_36_SER,3/4,80,9.0,3.0,no,no,no,3.0,3.0,2.5,1.0,3.0,12.5,frequent,0.0,1.0,0.0,2.0,3.0,6.0,IV,intermediate,Neocortical type,severe,SRR1568596,male
49,sample_SAMPLE_9630_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9630_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9630_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9630 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,648692,713359,0.909349,EXR-KJENS10CSF9630-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9630_CONTROL_CSF_fastq,96_30_CSF,3/3,90,,2.16,no,no,no,3.0,3.0,3.0,1.0,2.0,12.0,sparse,0.3,1.0,1.0,2.0,2.0,6.3,III,criteria not met,No Lewy bodies,none,SRR1568649,male
50,sample_SAMPLE_0442_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0442_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0442_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0442 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1042665,1058180,0.985338,EXR-KJENS10CSF0442-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0442_PD_CSF_fastq,04_42_CSF,2/3,73,13.0,2.0,no,no,no,3.0,3.0,3.0,1.0,2.25,12.25,moderate,0.5,0.0,0.0,0.5,1.25,2.25,II,low,Limbic type,severe,SRR1568465,male
51,sample_SAMPLE_0939_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0939_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0939_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0939 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,7690426,8058721,0.954299,EXR-KJENS10SER0939-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0939_AD_SER_fastq,09_39_SER,3/4,82,12.0,3.0,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,No Lewy bodies,none,SRR1568598,male
52,sample_SAMPLE_0662_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0662_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0662_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0662 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,10125040,11141095,0.908801,EXR-KJENS10SER0662-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0662_PD_SER_fastq,06_62_SER,3/3,82,18.0,4.16,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.5,0.0,3.0,3.0,6.5,III,criteria not met,Limbic type,severe,SRR1568519,female
53,sample_SAMPLE_0829_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0829_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0829_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0829 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2862597,2880299,0.993854,EXR-KJENS10SER0829-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0829_AD_SER_fastq,08_29_SER,3/3,90,1.0,3.75,no,no,no,2.5,2.5,2.5,1.0,3.0,11.5,frequent,0.0,0.0,0.0,1.5,2.0,3.5,III,intermediate,LB pathology unspecified or not further assessed,mild,SRR1568557,male
54,sample_SAMPLE_0335_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0335_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0335_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0335 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,4790361,4878740,0.981885,EXR-KJENS10CSF0335-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0335_PD_CSF_fastq,03_35_CSF,3/3,85,18.0,10.0,no,no,yes,2.5,2.5,3.0,1.25,1.75,11.0,moderate,1.0,2.5,2.0,2.0,2.25,9.75,IV,intermediate,Limbic type,severe,SRR1568438,female
55,sample_SAMPLE_0215_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0215_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0215_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0215 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3086384,3155711,0.978031,EXR-KJENS10CSF0215-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0215_PD_CSF_fastq,02_15_CSF,3/3,78,16.0,3.5,no,no,no,2.5,2.5,3.0,1.0,2.75,11.75,sparse,0.0,0.25,0.0,1.5,3.0,4.75,III,low,Neocortical type,severe,SRR1568400,female
56,sample_SAMPLE_9829_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9829_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9829_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9829 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,3350319,3490921,0.959724,EXR-KJENS10SER9829-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9829_PD_SER_fastq,98_29_SER,3/3,77,4.0,4.0,no,no,no,0.0,1.5,1.5,0.0,1.5,4.5,sparse,0.0,0.0,0.0,1.0,2.5,3.5,III,criteria not met,Neocortical type,severe,SRR1568703,male
57,sample_SAMPLE_9901_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9901_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9901_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9901 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,6284320,6409387,0.980487,EXR-KJENS10CSF9901-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9901_PD_CSF_fastq,99_01_CSF,3/3,83,9.0,5.25,no,no,yes,0.5,0.0,0.0,0.0,0.0,0.5,sparse,1.0,0.5,0.5,0.5,2.0,4.5,III,low,Limbic type,moderate,SRR1568710,male
58,sample_SAMPLE_0758_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0758_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0758_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0758 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,457717,488040,0.937868,EXR-KJENS10SER0758-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0758_CONTROL_SER_fastq,07_58_SER,3/3,88,,2.33,no,no,no,2.0,3.0,3.0,1.5,2.5,12.0,frequent,0.0,0.5,0.0,2.0,2.5,5.0,III,criteria not met,No Lewy bodies,mild,SRR1568543,female
59,sample_SAMPLE_0814_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0814_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0814_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0814 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,3069211,3288341,0.933362,EXR-KJENS10SER0814-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0814_PD_SER_fastq,08_14_SER,3/3,86,4.0,2.0,no,no,yes,2.0,2.5,2.5,2.0,2.5,11.5,moderate,1.5,1.5,1.0,2.5,3.0,9.5,III,criteria not met,Neocortical type,severe,SRR1568555,male
60,sample_SAMPLE_0651_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0651_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0651_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0651 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1731825,1867132,0.927532,EXR-KJENS10SER0651-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0651_PD_SER_fastq,06_51_SER,2/3,87,9.0,2.16,no,no,no,0.5,1.0,0.5,0.0,0.0,2.0,sparse,0.0,0.0,0.0,0.5,1.0,1.5,I,criteria not met,Limbic type,severe,SRR1568513,female
61,sample_SAMPLE_1036_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_1036_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_1036_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,1036 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,638080,648558,0.983844,EXR-KJENS10CSF1036-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_1036_AD_CSF_fastq,10_36_CSF,3/3,90,,4.5,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,V,high,No Lewy bodies,mild,SRR1568622,male
62,sample_SAMPLE_0605_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0605_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0605_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0605 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1908762,2463261,0.774892,EXR-KJENS10SER0605-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0605_CONTROL_SER_fastq,06_05_SER,2/3,88,,4.5,no,no,no,0.75,1.5,0.5,0.0,1.0,3.75,sparse,0.0,0.0,0.0,2.0,1.5,3.5,III,criteria not met,No Lewy bodies,mild,SRR1568492,female
63,sample_SAMPLE_0935_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0935_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0935_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0935 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,19442731,19598292,0.992063,EXR-KJENS10CSF0935-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0935_CONTROL_CSF_fastq,09_35_CSF,3/3,38,,3.0,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,0.0,0.0,0.0,0,criteria not met,No Lewy bodies,none,SRR1568593,male
64,sample_SAMPLE_0328_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0328_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0328_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0328 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3196310,3240286,0.986428,EXR-KJENS10CSF0328-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0328_CONTROL_CSF_fastq,03_28_CSF,3/3,80,,2.16,no,no,no,3.0,3.0,3.0,1.25,2.5,12.75,zero,0.0,0.0,0.0,0.5,0.5,1.0,I,criteria not met,No Lewy bodies,none,SRR1568428,male
65,sample_SAMPLE_9744_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9744_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9744_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9744 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3978319,4111653,0.967572,EXR-KJENS10CSF9744-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9744_AD_CSF_fastq,97_44_CSF,3/4,75,8.0,2.0,no,no,no,3.0,3.0,2.5,2.0,3.0,13.5,frequent,1.3,1.5,1.0,2.5,2.5,8.8,V,high,No Lewy bodies,none,SRR1568673,male
66,sample_SAMPLE_1037_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_1037_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_1037_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,1037 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,3371991,4333057,0.778201,EXR-KJENS10SER1037-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_1037_PD_SER_fastq,10_37_SER,3/3,84,,5.0,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.5,0.0,2.0,3.0,5.5,IV,criteria not met,Limbic type,severe,SRR1568625,female
67,sample_SAMPLE_9807_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9807_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9807_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9807 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,4887312,4958865,0.985571,EXR-KJENS10CSF9807-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9807_AD_CSF_fastq,98_07_CSF,3/3,85,1.0,2.5,no,no,no,2.2,3.0,2.5,1.0,0.0,8.7,moderate,0.0,0.0,0.0,1.0,,,III,intermediate,No Lewy bodies,none,SRR1568685,male
68,sample_SAMPLE_0931_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0931_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0931_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0931 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,897547,921391,0.974122,EXR-KJENS10SER0931-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0931_CONTROL_SER_fastq,09_31_SER,3/3,92,,2.66,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.5,2.0,0.0,3.0,3.0,8.5,IV,criteria not met,No Lewy bodies,mild,SRR1568592,male
69,sample_SAMPLE_0845_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0845_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0845_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0845 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,4948154,5017075,0.986263,EXR-KJENS10CSF0845-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0845_AD_CSF_fastq,08_45_CSF,3/4,78,5.0,2.25,no,no,no,3.0,3.0,3.0,2.0,3.0,14.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,No Lewy bodies,mild,SRR1568565,male
70,sample_SAMPLE_1027_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_1027_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_1027_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,1027 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,4113552,4194358,0.980735,EXR-KJENS10CSF1027-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_1027_PD_CSF_fastq,10_27_CSF,3/3,85,16.0,1.75,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.5,0.0,3.0,3.0,6.5,III,criteria not met,Neocortical type,severe,SRR1568616,female
71,sample_SAMPLE_0338_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0338_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0338_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0338 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,4549433,4605457,0.987835,EXR-KJENS10CSF0338-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0338_AD_CSF_fastq,03_38_CSF,3/4,84,14.0,3.5,no,no,no,3.0,2.5,3.0,2.25,2.75,13.5,frequent,3.0,3.0,2.5,3.0,3.0,14.5,VI,high,LB pathology unspecified or not further assessed,moderate,SRR1568440,female
72,sample_SAMPLE_0734_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0734_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0734_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0734 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,3504507,3530131,0.992741,EXR-KJENS10SER0734-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0734_AD_SER_fastq,07_34_SER,3/3,86,,2.5,no,no,no,3.0,3.0,3.0,1.5,1.0,11.5,frequent,3.0,3.0,0.0,3.0,3.0,12.0,IV,intermediate,No Lewy bodies,none,SRR1568534,female
73,sample_SAMPLE_0148_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0148_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0148_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0148 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1264276,1305076,0.968737,EXR-KJENS10CSF0148-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0148_AD_CSF_fastq,01_48_CSF,3/3,97,5.0,1.5,no,no,no,1.83,2.5,3.0,2.5,3.0,12.83,frequent,2.66,3.0,3.0,3.0,3.0,14.66,VI,high,LB pathology unspecified or not further assessed,moderate,SRR1568388,female
74,sample_SAMPLE_9815_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9815_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9815_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9815 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,3501597,3858400,0.907526,EXR-KJENS10SER9815-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9815_PD_SER_fastq,98_15_SER,2/3,88,1.0,2.66,no,no,no,2.25,2.0,1.5,0.0,1.0,6.75,moderate,0.0,0.25,0.0,2.0,2.0,4.25,III,intermediate,Neocortical type,mild,SRR1568692,male
75,sample_SAMPLE_1039_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_1039_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_1039_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,1039 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3199886,3290942,0.972331,EXR-KJENS10CSF1039-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_1039_CONTROL_CSF_fastq,10_39_CSF,3/3,93,,3.0,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,0.5,0.5,1.0,I,not AD,No Lewy bodies,none,SRR1568626,male
76,sample_SAMPLE_0027_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0027_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0027_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0027 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,4654684,4927548,0.944625,EXR-KJENS10CSF0027-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0027_PD_CSF_fastq,00_27_CSF,3/4,73,29.0,2.16,no,no,no,0.25,0.5,0.5,0.0,0.0,1.25,sparse,0.0,0.0,0.0,2.0,1.5,3.5,III,low,Neocortical type,severe,SRR1568364,female
77,sample_SAMPLE_9927_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9927_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9927_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9927 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,4525100,4576165,0.988841,EXR-KJENS10CSF9927-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9927_CONTROL_CSF_fastq,99_27_CSF,3/4,88,,2.0,no,no,no,1.75,2.0,2.5,1.5,1.5,9.25,sparse,0.0,0.0,0.0,2.5,2.5,5.0,III,criteria not met,No Lewy bodies,none,SRR1568731,female
78,sample_SAMPLE_9837_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9837_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9837_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9837 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3513364,3771187,0.931633,EXR-KJENS10CSF9837-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9837_CONTROL_CSF_fastq,98_37_CSF,3/4,78,,2.25,no,no,no,3.0,3.0,3.0,1.5,2.5,13.0,moderate,0.5,0.5,1.5,1.0,2.5,6.0,III,criteria not met,No Lewy bodies,none,SRR1568708,male
79,sample_SAMPLE_0855_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0855_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0855_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0855 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,9905477,10082887,0.982405,EXR-KJENS10CSF0855-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0855_CONTROL_CSF_fastq,08_55_CSF,3/3,71,,3.0,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,0.0,0.0,0.0,I,criteria not met,No Lewy bodies,none,SRR1568569,male
80,sample_SAMPLE_9905_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9905_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9905_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9905 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1301243,2134965,0.609491,EXR-KJENS10SER9905-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9905_PD_SER_fastq,99_05_SER,3/3,83,1.0,2.5,no,no,no,2.0,2.5,2.0,1.5,2.0,10.0,frequent,0.0,0.5,0.0,2.5,2.5,5.5,IV,intermediate,Limbic type,severe,SRR1568715,female
81,sample_SAMPLE_0438_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0438_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0438_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0438 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1853428,2062192,0.898766,EXR-KJENS10SER0438-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0438_CONTROL_SER_fastq,04_38_SER,2/2,83,,4.83,no,no,no,2.5,2.5,3.0,0.5,1.5,10.0,moderate,0.0,0.0,0.0,0.5,1.0,1.5,II,criteria not met,No Lewy bodies,none,SRR1568464,female
82,sample_SAMPLE_0511_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0511_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0511_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0511 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1396761,1474881,0.947033,EXR-KJENS10SER0511-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0511_AD_SER_fastq,05_11_SER,3/3,86,9.0,2.5,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,2.5,3.0,2.5,3.0,3.0,14.0,V,high,No Lewy bodies,mild,SRR1568475,female
83,sample_SAMPLE_9630_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9630_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_9630_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9630 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,179512,183654,0.977447,EXR-KJENS10SER9630-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9630_CONTROL_SER_fastq,96_30_SER,3/3,90,,2.16,no,no,no,3.0,3.0,3.0,1.0,2.0,12.0,sparse,0.3,1.0,1.0,2.0,2.0,6.3,III,criteria not met,No Lewy bodies,none,SRR1568650,male
84,sample_SAMPLE_0422_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0422_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0422_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0422 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,2408395,2440586,0.98681,EXR-KJENS10CSF0422-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0422_AD_CSF_fastq,04_22_CSF,3/4,80,8.0,7.0,no,no,no,2.5,3.0,2.5,1.5,2.75,12.25,frequent,2.5,3.0,2.5,3.0,3.0,14.0,V,high,No Lewy bodies,mild,SRR1568454,male
85,sample_SAMPLE_0149_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0149_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0149_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0149 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,436376,707045,0.617183,EXR-KJENS10SER0149-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0149_PD_SER_fastq,01_49_SER,3/3,79,6.0,2.0,no,no,no,3.0,2.75,3.0,2.0,2.0,12.75,moderate,0.0,1.25,0.0,3.0,3.0,7.25,IV,intermediate,Brainstem predominant type,mild,SRR1568390,female
86,sample_SAMPLE_9834_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9834_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9834_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9834 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,10630217,11175103,0.951241,EXR-KJENS10CSF9834-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9834_CONTROL_CSF_fastq,98_34_CSF,3/4,73,,1.5,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.5,0.0,0.0,1.0,1.5,I,criteria not met,No Lewy bodies,none,SRR1568706,female
87,sample_SAMPLE_9829_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9829_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9829_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9829 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1401148,1416429,0.989212,EXR-KJENS10CSF9829-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9829_PD_CSF_fastq,98_29_CSF,3/3,77,4.0,4.0,no,no,no,0.0,1.5,1.5,0.0,1.5,4.5,sparse,0.0,0.0,0.0,1.0,2.5,3.5,III,criteria not met,Neocortical type,severe,SRR1568702,male
88,sample_SAMPLE_0233_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0233_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0233_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0233 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,FAIL,196236,621859,0.315563,EXR-KJENS10SER0233-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0233_CONTROL_SER_fastq,02_33_SER,3/3,85,,2.25,no,no,no,1.5,2.0,2.0,0.0,2.75,8.25,moderate,0.0,1.0,0.0,1.5,2.5,5.0,III,criteria not met,No Lewy bodies,none,SRR1568405,male
89,sample_SAMPLE_9902_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9902_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_9902_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9902 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1769769,2521988,0.701736,EXR-KJENS10SER9902-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9902_CONTROL_SER_fastq,99_02_SER,4/4,70,,2.0,no,no,no,1.5,2.0,2.0,1.0,1.75,8.25,sparse,0.0,0.0,0.0,0.0,0.0,0.0,I,criteria not met,No Lewy bodies,none,SRR1568713,female
90,sample_SAMPLE_0741_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0741_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0741_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0741 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2120229,2203707,0.962119,EXR-KJENS10SER0741-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0741_PD_SER_fastq,07_41_SER,3/3,76,9.0,4.83,no,no,no,3.0,3.0,1.5,2.5,3.0,13.0,frequent,0.5,2.0,0.0,3.0,3.0,8.5,IV,intermediate,Neocortical type,severe,SRR1568536,male
91,sample_SAMPLE_0430_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0430_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0430_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0430 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2828133,2890527,0.978414,EXR-KJENS10SER0430-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0430_CONTROL_SER_fastq,04_30_SER,2/3,78,,3.75,no,no,no,1.5,2.5,2.5,1.5,2.0,10.0,moderate,1.0,3.0,3.0,2.25,3.0,12.25,IV,criteria not met,No Lewy bodies,none,SRR1568460,female
92,sample_SAMPLE_9834_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9834_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_9834_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9834 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2154236,4279247,0.503415,EXR-KJENS10SER9834-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9834_CONTROL_SER_fastq,98_34_SER,3/4,73,,1.5,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.5,0.0,0.0,1.0,1.5,I,criteria not met,No Lewy bodies,none,SRR1568707,female
93,sample_SAMPLE_0763_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0763_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0763_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0763 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3824523,3917329,0.976309,EXR-KJENS10CSF0763-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0763_CONTROL_CSF_fastq,07_63_CSF,3/3,87,,2.5,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,2.0,2.5,4.5,IV,criteria not met,No Lewy bodies,none,SRR1568544,female
94,sample_SAMPLE_0521_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0521_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0521_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0521 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1480125,1509389,0.980612,EXR-KJENS10CSF0521-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0521_CONTROL_CSF_fastq,05_21_CSF,3/3,91,7.0,2.5,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,1.0,0.0,3.0,3.0,7.0,IV,criteria not met,No Lewy bodies,mild,SRR1568484,male
95,sample_SAMPLE_9431_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9431_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9431_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9431 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,591478,1027453,0.575674,EXR-KJENS10SER9431-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9431_PD_SER_fastq,94_31_SER,,83,4.0,2.16,no,no,no,1.0,0.5,1.0,0.0,0.0,2.5,zero,0.0,0.0,0.0,2.0,3.0,6.0,III,criteria not met,LB pathology unspecified or not further assessed,severe,SRR1568629,male
96,sample_SAMPLE_9915_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9915_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9915_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9915 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,124689,140165,0.889587,EXR-KJENS10SER9915-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9915_AD_SER_fastq,99_15_SER,4/4,83,8.0,2.83,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,No Lewy bodies,none,SRR1568723,male
97,sample_SAMPLE_9944_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9944_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_9944_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9944 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1829952,1956501,0.935319,EXR-KJENS10SER9944-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9944_CONTROL_SER_fastq,99_44_SER,3/4,69,,2.16,no,no,no,1.5,1.5,2.0,1.0,1.5,7.5,sparse,0.0,0.0,0.0,0.0,0.0,0.0,I,criteria not met,No Lewy bodies,none,SRR1568742,male
98,sample_SAMPLE_0758_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0758_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0758_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0758 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,7144048,7300369,0.978587,EXR-KJENS10CSF0758-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0758_CONTROL_CSF_fastq,07_58_CSF,3/3,88,,2.33,no,no,no,2.0,3.0,3.0,1.5,2.5,12.0,frequent,0.0,0.5,0.0,2.0,2.5,5.0,III,criteria not met,No Lewy bodies,mild,SRR1568542,female
99,sample_SAMPLE_0742_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0742_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0742_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0742 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1387446,1407826,0.985524,EXR-KJENS10SER0742-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0742_AD_SER_fastq,07_42_SER,3/4,65,3.0,2.75,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,No Lewy bodies,none,SRR1568538,female
100,sample_SAMPLE_0335_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0335_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0335_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0335 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,850693,1413911,0.60166,EXR-KJENS10SER0335-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0335_PD_SER_fastq,03_35_SER,3/3,85,18.0,10.0,no,no,yes,2.5,2.5,3.0,1.25,1.75,11.0,moderate,1.0,2.5,2.0,2.0,2.25,9.75,IV,intermediate,Limbic type,severe,SRR1568439,female
101,sample_SAMPLE_0217_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0217_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0217_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0217 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,4016163,4197714,0.95675,EXR-KJENS10CSF0217-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0217_PD_CSF_fastq,02_17_CSF,3/4,82,22.0,3.0,no,no,no,2.0,1.25,1.5,1.0,1.25,7.0,sparse,0.0,0.0,0.0,3.0,2.5,5.5,III,low,Limbic type,severe,SRR1568402,female
102,sample_SAMPLE_0814_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0814_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0814_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0814 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,12615055,12766353,0.988149,EXR-KJENS10CSF0814-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0814_PD_CSF_fastq,08_14_CSF,3/3,86,4.0,2.0,no,no,yes,2.0,2.5,2.5,2.0,2.5,11.5,moderate,1.5,1.5,1.0,2.5,3.0,9.5,III,criteria not met,Neocortical type,severe,SRR1568554,male
103,sample_SAMPLE_9936_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9936_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9936_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9936 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,2108572,2131956,0.989032,EXR-KJENS10CSF9936-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9936_PD_CSF_fastq,99_36_CSF,3/4,76,2.0,3.25,no,no,no,1.5,1.5,1.5,1.5,2.0,8.0,moderate,0.25,1.5,0.0,2.5,1.75,6.0,IV,intermediate,Neocortical type,severe,SRR1568736,male
104,sample_SAMPLE_9837_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9837_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_9837_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9837 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1380847,2021983,0.682917,EXR-KJENS10SER9837-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9837_CONTROL_SER_fastq,98_37_SER,3/4,78,,2.25,no,no,no,3.0,3.0,3.0,1.5,2.5,13.0,moderate,0.5,0.5,1.5,1.0,2.5,6.0,III,criteria not met,No Lewy bodies,none,SRR1568709,male
105,sample_SAMPLE_9635_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9635_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9635_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9635 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,5932015,5979751,0.992017,EXR-KJENS10CSF9635-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9635_CONTROL_CSF_fastq,96_35_CSF,2/3,84,,2.66,no,no,no,1.5,1.5,1.5,1.5,1.0,7.0,sparse,0.0,1.0,1.0,1.0,1.0,4.0,III,criteria not met,No Lewy bodies,none,SRR1568653,male
106,sample_SAMPLE_0931_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0931_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0931_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0931 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1277139,1311680,0.973667,EXR-KJENS10CSF0931-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0931_CONTROL_CSF_fastq,09_31_CSF,3/3,92,,2.66,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.5,2.0,0.0,3.0,3.0,8.5,IV,criteria not met,No Lewy bodies,mild,SRR1568591,male
107,sample_SAMPLE_0539_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0539_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0539_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0539 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3094529,3128861,0.989027,EXR-KJENS10CSF0539-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0539_AD_CSF_fastq,05_39_CSF,3/4,82,9.0,3.0,no,no,no,3.0,3.0,3.0,2.0,2.75,13.75,frequent,0.75,1.0,0.5,3.0,3.0,8.25,IV,intermediate,No Lewy bodies,mild,SRR1568488,male
108,sample_SAMPLE_9963_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9963_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9963_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9963 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,8069777,8192574,0.985011,EXR-KJENS10SER9963-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9963_PD_SER_fastq,99_63_SER,3/3,85,0.0,2.66,no,no,no,1.5,1.0,1.5,0.0,0.75,4.75,sparse,0.0,0.5,0.0,1.5,1.5,3.5,III,low,Limbic type,severe,SRR1568754,male
109,sample_SAMPLE_1026_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_1026_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_1026_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,1026 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2509808,2568332,0.977213,EXR-KJENS10SER1026-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_1026_CONTROL_SER_fastq,10_26_SER,3/3,95,2.0,2.5,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.5,0.0,3.0,3.0,6.5,III,criteria not met,No Lewy bodies,none,SRR1568615,female
110,sample_SAMPLE_9960_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9960_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9960_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9960 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,6676632,6771916,0.98593,EXR-KJENS10CSF9960-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9960_AD_CSF_fastq,99_60_CSF,3/4,83,3.0,4.16,no,no,no,2.5,2.0,2.5,1.0,2.0,10.0,moderate,0.0,0.0,0.0,1.0,2.5,3.5,III,intermediate,No Lewy bodies,none,SRR1568751,male
111,sample_SAMPLE_1013_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_1013_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_1013_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,1013 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,2067157,2160371,0.956853,EXR-KJENS10CSF1013-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_1013_CONTROL_CSF_fastq,10_13_CSF,,85,,3.0,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,1.5,2.5,4.0,III,criteria not met,No Lewy bodies,none,SRR1568608,male
112,sample_SAMPLE_0351_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0351_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0351_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0351 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2444435,2531885,0.965461,EXR-KJENS10SER0351-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0351_PD_SER_fastq,03_51_SER,3/3,70,30.0,2.33,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,0.5,1.5,2.0,II,low,Limbic type,severe,SRR1568444,male
113,sample_SAMPLE_0763_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0763_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0763_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0763 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1614497,2021752,0.798563,EXR-KJENS10SER0763-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0763_CONTROL_SER_fastq,07_63_SER,3/3,87,,2.5,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,2.0,2.5,4.5,IV,criteria not met,No Lewy bodies,none,SRR1568545,female
114,sample_SAMPLE_0865_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0865_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0865_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0865 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,7798892,7920499,0.984647,EXR-KJENS10CSF0865-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0865_PD_CSF_fastq,08_65_CSF,2/3,74,17.0,8.75,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,1.5,1.5,3.0,III,criteria not met,Limbic type,severe,SRR1568571,male
115,sample_SAMPLE_9807_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9807_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9807_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9807 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,3400203,3992989,0.851543,EXR-KJENS10SER9807-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9807_AD_SER_fastq,98_07_SER,3/3,85,1.0,2.5,no,no,no,2.2,3.0,2.5,1.0,0.0,8.7,moderate,0.0,0.0,0.0,1.0,,,III,intermediate,No Lewy bodies,none,SRR1568686,male
116,sample_SAMPLE_1032_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_1032_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_1032_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,1032 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,FAIL,1408965,2830750,0.497736,EXR-KJENS10SER1032-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_1032_CONTROL_SER_fastq,10_32_SER,3/4,84,,2.51,no,no,no,3.0,3.0,3.0,2.0,2.5,13.5,frequent,0.5,1.0,0.0,2.5,3.0,7.0,IV,criteria not met,No Lewy bodies,none,SRR1568621,female
117,sample_SAMPLE_9958_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9958_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9958_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9958 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,968134,996976,0.971071,EXR-KJENS10CSF9958-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9958_CONTROL_CSF_fastq,99_58_CSF,2/2,91,,2.5,no,no,no,0.0,0.0,1.0,0.0,0.0,1.0,sparse,0.0,0.0,0.0,1.5,2.5,4.0,III,criteria not met,No Lewy bodies,none,SRR1568749,female
118,sample_SAMPLE_9936_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9936_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9936_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9936 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,459346,500107,0.918495,EXR-KJENS10SER9936-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9936_PD_SER_fastq,99_36_SER,3/4,76,2.0,3.25,no,no,no,1.5,1.5,1.5,1.5,2.0,8.0,moderate,0.25,1.5,0.0,2.5,1.75,6.0,IV,intermediate,Neocortical type,severe,SRR1568737,male
119,sample_SAMPLE_0621_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0621_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0621_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0621 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,6777374,7477389,0.906382,EXR-KJENS10CSF0621-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0621_CONTROL_CSF_fastq,06_21_CSF,2/3,73,,2.5,no,no,no,1.0,2.0,0.5,0.0,2.0,5.5,sparse,0.0,0.0,0.0,1.0,2.0,3.0,II,criteria not met,No Lewy bodies,mild,SRR1568501,male
120,sample_SAMPLE_0663_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0663_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0663_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0663 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,15080249,15276039,0.987183,EXR-KJENS10CSF0663-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0663_CONTROL_CSF_fastq,06_63_CSF,3/3,84,,3.25,no,no,no,3.0,3.0,3.0,2.0,3.0,14.0,frequent,0.0,0.5,0.0,2.5,3.0,6.0,III,criteria not met,No Lewy bodies,mild,SRR1568520,female
121,sample_SAMPLE_9718_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9718_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9718_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9718 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1126705,1141401,0.987125,EXR-KJENS10CSF9718-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9718_AD_CSF_fastq,97_18_CSF,4/4,93,3.0,2.5,no,no,no,3.0,3.0,2.5,2.5,3.0,14.0,frequent,3.0,3.0,2.5,3.0,3.0,14.5,VI,high,No Lewy bodies,mild,SRR1568661,female
122,sample_SAMPLE_1032_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_1032_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_1032_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,1032 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,2202492,2274028,0.968542,EXR-KJENS10CSF1032-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_1032_CONTROL_CSF_fastq,10_32_CSF,3/4,84,,2.51,no,no,no,3.0,3.0,3.0,2.0,2.5,13.5,frequent,0.5,1.0,0.0,2.5,3.0,7.0,IV,criteria not met,No Lewy bodies,none,SRR1568620,female
123,sample_SAMPLE_9803_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9803_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9803_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9803 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1945168,1960780,0.992038,EXR-KJENS10CSF9803-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9803_PD_CSF_fastq,98_03_CSF,3/3,72,27.0,3.0,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.5,0.0,1.0,2.0,1.0,4.5,I,criteria not met,Neocortical type,severe,SRR1568683,male
124,sample_SAMPLE_0520_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0520_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0520_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0520 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,3277312,3395319,0.965244,EXR-KJENS10SER0520-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0520_CONTROL_SER_fastq,05_20_SER,3/3,75,3.0,4.33,no,no,no,3.0,3.0,3.0,2.0,3.0,14.0,frequent,0.5,1.0,0.5,3.0,3.0,8.0,IV,criteria not met,No Lewy bodies,none,SRR1568483,male
125,sample_SAMPLE_9952_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9952_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9952_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9952 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,3023802,3569283,0.847174,EXR-KJENS10SER9952-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9952_AD_SER_fastq,99_52_SER,3/3,89,9.0,4.0,no,no,no,3.0,2.0,3.0,1.0,1.75,10.75,moderate,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,LB pathology unspecified or not further assessed,moderate,SRR1568748,female
126,sample_SAMPLE_9927_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9927_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_9927_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9927 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1371764,2197659,0.624193,EXR-KJENS10SER9927-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9927_CONTROL_SER_fastq,99_27_SER,3/4,88,,2.0,no,no,no,1.75,2.0,2.5,1.5,1.5,9.25,sparse,0.0,0.0,0.0,2.5,2.5,5.0,III,criteria not met,No Lewy bodies,none,SRR1568732,female
127,sample_SAMPLE_0312_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0312_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0312_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0312 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,6094678,6181769,0.985912,EXR-KJENS10SER0312-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0312_CONTROL_SER_fastq,03_12_SER,3/4,88,,7.0,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.25,0.0,1.5,1.25,3.0,III,criteria not met,No Lewy bodies,none,SRR1568416,female
128,sample_SAMPLE_0316_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0316_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0316_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0316 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3239303,3285582,0.985915,EXR-KJENS10CSF0316-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0316_PD_CSF_fastq,03_16_CSF,2/3,82,13.0,3.25,no,yes,no,2.5,2.0,2.5,0.0,1.75,8.75,moderate,0.0,0.0,0.0,0.25,0.75,1.0,II,intermediate,Neocortical type,severe,SRR1568418,male
129,sample_SAMPLE_0325_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0325_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0325_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0325 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,2485657,2515912,0.987975,EXR-KJENS10CSF0325-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0325_PD_CSF_fastq,03_25_CSF,3/3,78,19.0,2.5,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,1.5,0.25,1.75,III,criteria not met,Brainstem predominant type,severe,SRR1568426,male
130,sample_SAMPLE_0942_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0942_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0942_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0942 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,811949,1143211,0.710235,EXR-KJENS10SER0942-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0942_AD_SER_fastq,09_42_SER,3/3,85,5.0,3.0,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,No Lewy bodies,none,SRR1568600,male
131,sample_SAMPLE_0358_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0358_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0358_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0358 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,4626344,4700188,0.984289,EXR-KJENS10CSF0358-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0358_CONTROL_CSF_fastq,03_58_CSF,3/4,85,,1.5,no,no,no,3.0,2.5,2.5,0.0,2.25,10.25,moderate,0.0,0.5,0.0,2.25,2.5,5.25,III,criteria not met,No Lewy bodies,none,SRR1568447,female
132,sample_SAMPLE_0949_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0949_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0949_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0949 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,2305038,2343824,0.983452,EXR-KJENS10CSF0949-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0949_CONTROL_CSF_fastq,09_49_CSF,3/3,97,1.0,3.0,no,no,no,0.0,0.5,0.0,0.0,0.0,0.5,sparse,0.0,0.5,0.0,1.0,1.5,3.0,III,criteria not met,No Lewy bodies,none,SRR1568601,male
133,sample_SAMPLE_9901_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9901_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9901_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9901 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1406450,2109624,0.666683,EXR-KJENS10SER9901-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9901_PD_SER_fastq,99_01_SER,3/3,83,9.0,5.25,no,no,yes,0.5,0.0,0.0,0.0,0.0,0.5,sparse,1.0,0.5,0.5,0.5,2.0,4.5,III,low,Limbic type,moderate,SRR1568711,male
134,sample_SAMPLE_0519_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0519_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0519_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0519 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,4784096,4815360,0.993507,EXR-KJENS10CSF0519-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0519_AD_CSF_fastq,05_19_CSF,3/3,75,5.0,2.83,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,2.5,3.0,2.5,2.5,3.0,13.5,V,high,No Lewy bodies,mild,SRR1568480,female
135,sample_SAMPLE_9917_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9917_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9917_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9917 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,10995934,11303282,0.972809,EXR-KJENS10CSF9917-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9917_PD_CSF_fastq,99_17_CSF,3/3,83,21.0,12.0,no,no,no,0.5,0.0,1.0,0.0,0.0,1.5,sparse,0.0,0.5,0.0,1.5,2.25,4.25,III,criteria not met,Limbic type,severe,SRR1568724,female
136,sample_SAMPLE_0307_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0307_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0307_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0307 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,FAIL,173112,429539,0.403018,EXR-KJENS10SER0307-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0307_AD_SER_fastq,03_07_SER,3/4,67,9.0,2.0,no,no,no,2.5,2.5,2.5,1.0,2.5,11.0,frequent,3.0,3.0,3.0,2.5,3.0,14.5,V,high,No Lewy bodies,none,SRR1568411,male
137,sample_SAMPLE_0517_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0517_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0517_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0517 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,4872577,4991187,0.976236,EXR-KJENS10CSF0517-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0517_PD_CSF_fastq,05_17_CSF,3/3,84,23.0,2.0,no,no,no,0.0,1.0,0.0,0.0,1.0,2.0,zero,0.0,0.0,0.0,0.5,1.0,1.5,II,low,Limbic type,severe,SRR1568478,female
138,sample_SAMPLE_0915_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0915_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0915_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0915 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2606546,2730435,0.954627,EXR-KJENS10SER0915-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0915_PD_SER_fastq,09_15_SER,3/3,84,17.0,3.75,no,no,no,3.0,3.0,3.0,2.0,3.0,14.0,frequent,0.0,0.5,0.5,3.0,3.0,7.0,IV,intermediate,Neocortical type,severe,SRR1568588,male
139,sample_SAMPLE_0708_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0708_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0708_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0708 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,6401629,6488750,0.986574,EXR-KJENS10CSF0708-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0708_AD_CSF_fastq,07_08_CSF,3/4,70,5.0,3.5,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,No Lewy bodies,,SRR1568524,female
140,sample_SAMPLE_0142_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0142_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0142_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0142 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2074071,2262981,0.916522,EXR-KJENS10SER0142-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0142_PD_SER_fastq,01_42_SER,3/3,85,15.0,4.0,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,2.0,1.25,3.25,II,criteria not met,Limbic type,severe,SRR1568383,male
141,sample_SAMPLE_0358_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0358_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0358_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0358 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2601548,4512481,0.576523,EXR-KJENS10SER0358-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0358_CONTROL_SER_fastq,03_58_SER,3/4,85,,1.5,no,no,no,3.0,2.5,2.5,0.0,2.25,10.25,moderate,0.0,0.5,0.0,2.25,2.5,5.25,III,criteria not met,No Lewy bodies,none,SRR1568448,female
142,sample_SAMPLE_0608_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0608_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0608_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0608 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,FAIL,692811,2232152,0.310378,EXR-KJENS10SER0608-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0608_CONTROL_SER_fastq,06_08_SER,3/3,84,,2.5,no,no,no,1.5,2.5,0.5,1.0,1.0,6.5,frequent,0.0,0.0,0.0,0.5,1.5,2.0,II,criteria not met,No Lewy bodies,none,SRR1568494,male
143,sample_SAMPLE_9749_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9749_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9749_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9749 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1992475,2448674,0.813695,EXR-KJENS10SER9749-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9749_PD_SER_fastq,97_49_SER,3/4,88,0.0,3.66,no,no,no,1.5,2.0,2.5,0.0,0.5,6.5,moderate,0.5,0.0,0.0,1.0,1.0,2.5,I,intermediate,Neocortical type,severe,SRR1568680,male
144,sample_SAMPLE_9617_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9617_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9617_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9617 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,15592443,15783128,0.987918,EXR-KJENS10SER9617-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9617_AD_SER_fastq,96_17_SER,3/4,86,10.0,2.75,no,no,no,3.0,3.0,2.5,3.0,3.0,14.5,frequent,2.5,3.0,3.0,3.0,3.0,14.5,V,high,LB pathology unspecified or not further assessed,severe,SRR1568643,female
145,sample_SAMPLE_9824_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9824_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9824_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9824 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,2914773,2991512,0.974348,EXR-KJENS10CSF9824-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9824_PD_CSF_fastq,98_24_CSF,2/3,81,8.0,2.5,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,1.5,1.0,2.5,I,criteria not met,Neocortical type,moderate,SRR1568700,male
146,sample_SAMPLE_0711_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0711_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0711_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0711 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,4943270,5038906,0.98102,EXR-KJENS10CSF0711-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0711_CONTROL_CSF_fastq,07_11_CSF,3/4,75,,2.75,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,2.0,3.0,5.0,III,criteria not met,No Lewy bodies,none,SRR1568527,female
147,sample_SAMPLE_9914_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9914_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9914_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9914 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1515651,1571962,0.964178,EXR-KJENS10CSF9914-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9914_CONTROL_CSF_fastq,99_14_CSF,3/3,86,,2.5,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.5,0.0,1.0,2.0,3.5,II,criteria not met,No Lewy bodies,none,SRR1568720,male
148,sample_SAMPLE_9618_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9618_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9618_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9618 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,5419698,5517022,0.982359,EXR-KJENS10CSF9618-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9618_AD_CSF_fastq,96_18_CSF,4/4,79,14.0,2.5,no,no,no,3.0,3.0,2.0,3.0,3.0,14.0,frequent,1.0,2.0,1.0,3.0,3.0,10.0,IV,intermediate,,moderate,SRR1568644,female
149,sample_SAMPLE_0885_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0885_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0885_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0885 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,5268811,5305093,0.993161,EXR-KJENS10CSF0885-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0885_CONTROL_CSF_fastq,08_85_CSF,2/3,82,,3.66,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.5,0.0,3.0,3.0,6.5,III,criteria not met,No Lewy bodies,none,SRR1568581,male
150,sample_SAMPLE_0741_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0741_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0741_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0741 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1585719,1631786,0.971769,EXR-KJENS10CSF0741-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0741_PD_CSF_fastq,07_41_CSF,3/3,76,9.0,4.83,no,no,no,3.0,3.0,1.5,2.5,3.0,13.0,frequent,0.5,2.0,0.0,3.0,3.0,8.5,IV,intermediate,Neocortical type,severe,SRR1568535,male
151,sample_SAMPLE_0217_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0217_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0217_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0217 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,FAIL,295494,1069537,0.276282,EXR-KJENS10SER0217-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0217_PD_SER_fastq,02_17_SER,3/4,82,22.0,3.0,no,no,no,2.0,1.25,1.5,1.0,1.25,7.0,sparse,0.0,0.0,0.0,3.0,2.5,5.5,III,low,Limbic type,severe,SRR1568403,female
152,sample_SAMPLE_9819_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9819_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9819_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9819 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1967321,2002136,0.982611,EXR-KJENS10CSF9819-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9819_CONTROL_CSF_fastq,98_19_CSF,3/3,87,,4.0,no,no,no,0.7,0.0,0.5,0.0,1.0,2.2,sparse,0.0,0.0,0.0,1.5,1.0,2.5,III,criteria not met,No Lewy bodies,none,SRR1568695,female
153,sample_SAMPLE_0511_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0511_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0511_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0511 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,2000243,2035505,0.982677,EXR-KJENS10CSF0511-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0511_AD_CSF_fastq,05_11_CSF,3/3,86,9.0,2.5,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,2.5,3.0,2.5,3.0,3.0,14.0,V,high,No Lewy bodies,mild,SRR1568474,female
154,sample_SAMPLE_0888_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0888_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0888_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0888 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1361367,1459647,0.932669,EXR-KJENS10CSF0888-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0888_CONTROL_CSF_fastq,08_88_CSF,3/3,65,,3.5,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,0.5,0.5,1.0,I,criteria not met,No Lewy bodies,none,SRR1568583,male
155,sample_SAMPLE_0615_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0615_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0615_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0615 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,8858922,8944584,0.990423,EXR-KJENS10SER0615-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0615_CONTROL_SER_fastq,06_15_SER,2/3,87,,2.5,no,no,no,1.5,1.5,1.5,0.0,0.0,4.5,moderate,0.0,0.25,0.0,1.5,2.5,4.25,III,criteria not met,No Lewy bodies,mild,SRR1568498,female
156,sample_SAMPLE_0118_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0118_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0118_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0118 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,29248898,30791190,0.949911,EXR-KJENS10SER0118-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0118_AD_SER_fastq,01_18_SER,3/3,86,21.0,3.0,no,no,no,3.0,3.0,3.0,3.0,2.25,14.25,moderate,1.0,1.75,2.5,3.0,3.0,11.25,V,high,No Lewy bodies,severe,SRR1568371,male
157,sample_SAMPLE_0144_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0144_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0144_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0144 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3619801,3691691,0.980527,EXR-KJENS10CSF0144-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0144_CONTROL_CSF_fastq,01_44_CSF,3/3,78,,2.83,no,no,no,2.33,1.75,2.0,1.0,1.75,8.83,moderate,0.0,0.0,0.0,1.5,2.75,4.25,III,criteria not met,No Lewy bodies,moderate,SRR1568384,female
158,sample_SAMPLE_0204_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0204_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0204_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0204 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,7495853,7600126,0.98628,EXR-KJENS10CSF0204-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0204_CONTROL_CSF_fastq,02_04_CSF,3/3,80,,2.0,no,no,no,1.25,0.5,0.0,0.0,0.0,1.75,moderate,0.0,0.0,0.0,1.5,2.0,3.5,III,criteria not met,No Lewy bodies,none,SRR1568393,female
159,sample_SAMPLE_9929_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9929_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9929_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9929 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,2263553,2289633,0.98861,EXR-KJENS10CSF9929-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9929_CONTROL_CSF_fastq,99_29_CSF,2/3,81,,3.75,no,no,no,1.5,1.5,1.5,2.0,2.0,8.5,sparse,0.0,1.0,0.0,3.0,3.0,7.0,IV,criteria not met,No Lewy bodies,none,SRR1568735,male
160,sample_SAMPLE_9803_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9803_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9803_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9803 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,6578585,6629897,0.992261,EXR-KJENS10SER9803-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9803_PD_SER_fastq,98_03_SER,3/3,72,27.0,3.0,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.5,0.0,1.0,2.0,1.0,4.5,I,criteria not met,Neocortical type,severe,SRR1568684,male
161,sample_SAMPLE_0608_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0608_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0608_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0608 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,6320162,6448365,0.980119,EXR-KJENS10CSF0608-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0608_CONTROL_CSF_fastq,06_08_CSF,3/3,84,,2.5,no,no,no,1.5,2.5,0.5,1.0,1.0,6.5,frequent,0.0,0.0,0.0,0.5,1.5,2.0,II,criteria not met,No Lewy bodies,none,SRR1568493,male
162,sample_SAMPLE_0462_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0462_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0462_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0462 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2294673,2431031,0.943909,EXR-KJENS10SER0462-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0462_CONTROL_SER_fastq,04_62_SER,3/3,86,,1.5,no,no,no,1.0,2.0,1.0,0.0,2.0,6.0,moderate,0.0,0.0,0.0,2.5,2.5,5.0,IV,criteria not met,No Lewy bodies,none,SRR1568470,female
163,sample_SAMPLE_0870_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0870_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0870_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0870 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,31230183,31824752,0.981317,EXR-KJENS10CSF0870-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0870_PD_CSF_fastq,08_70_CSF,2/3,75,16.0,2.33,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,2.0,3.0,5.0,IV,criteria not met,Limbic type,severe,SRR1568575,male
164,sample_SAMPLE_0207_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0207_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0207_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0207 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1538363,1557192,0.987908,EXR-KJENS10CSF0207-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0207_AD_CSF_fastq,02_07_CSF,3/4,83,8.0,3.25,no,no,no,3.0,3.0,3.0,2.0,3.0,14.0,frequent,1.5,3.0,1.5,3.0,3.0,12.0,V,high,LB pathology unspecified or not further assessed,,SRR1568397,male
165,sample_SAMPLE_0619_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0619_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0619_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0619 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,2552644,2584229,0.987778,EXR-KJENS10CSF0619-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0619_CONTROL_CSF_fastq,06_19_CSF,2/3,84,,4.25,no,no,no,1.5,1.5,2.0,1.0,1.0,7.0,moderate,0.0,0.25,0.0,0.5,0.5,1.25,II,criteria not met,No Lewy bodies,none,SRR1568499,male
166,sample_SAMPLE_0519_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0519_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0519_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0519 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,4227754,4398989,0.961074,EXR-KJENS10SER0519-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0519_AD_SER_fastq,05_19_SER,3/3,75,5.0,2.83,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,2.5,3.0,2.5,2.5,3.0,13.5,V,high,No Lewy bodies,mild,SRR1568481,female
167,sample_SAMPLE_0837_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0837_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0837_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0837 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,8517809,8783258,0.969778,EXR-KJENS10CSF0837-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0837_AD_CSF_fastq,08_37_CSF,2/3,87,6.0,2.5,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,2.5,3.0,3.0,3.0,3.0,14.5,VI,high,No Lewy bodies,mild,SRR1568561,male
168,sample_SAMPLE_0702_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0702_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0702_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0702 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,5862555,5938403,0.987228,EXR-KJENS10CSF0702-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0702_AD_CSF_fastq,07_02_CSF,3/3,87,5.0,3.0,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,V,high,No Lewy bodies,mild,SRR1568522,female
169,sample_SAMPLE_9948_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9948_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9948_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9948 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,5972305,6012078,0.993384,EXR-KJENS10CSF9948-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9948_AD_CSF_fastq,99_48_CSF,3/4,85,5.0,2.25,no,no,no,2.75,2.5,3.0,2.5,2.75,13.5,moderate,0.0,2.5,0.0,3.0,3.0,8.5,IV,intermediate,No Lewy bodies,none,SRR1568743,female
170,sample_SAMPLE_0655_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0655_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0655_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0655 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,27992080,28669163,0.976383,EXR-KJENS10CSF0655-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0655_PD_CSF_fastq,06_55_CSF,2/3,83,15.0,4.33,no,no,yes,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.5,0.0,0.0,0.0,0.0,0.5,0,criteria not met,Limbic type,severe,SRR1568516,male
171,sample_SAMPLE_9810_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9810_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9810_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9810 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,108592,124609,0.871462,EXR-KJENS10SER9810-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9810_AD_SER_fastq,98_10_SER,3/4,82,7.0,2.25,no,no,no,2.5,3.0,3.0,2.0,2.5,13.0,frequent,2.0,3.0,2.0,3.0,3.0,13.0,V,high,LB pathology unspecified or not further assessed,mild,SRR1568688,male
172,sample_SAMPLE_9646_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9646_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9646_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9646 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1575564,1591476,0.990002,EXR-KJENS10CSF9646-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9646_AD_CSF_fastq,96_46_CSF,4/4,87,9.0,2.0,no,no,no,3.0,3.0,2.0,3.0,3.0,14.0,moderate,1.0,2.0,1.0,3.0,3.0,10.0,IV,intermediate,No Lewy bodies,mild,SRR1568655,male
173,sample_SAMPLE_0239_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0239_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0239_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0239 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,4943974,5081277,0.972979,EXR-KJENS10SER0239-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0239_AD_SER_fastq,02_39_SER,3/4,75,10.0,3.0,no,no,no,3.0,3.0,3.0,2.0,3.0,14.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,V,high,No Lewy bodies,none,SRR1568407,male
174,sample_SAMPLE_9902_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9902_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9902_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9902 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3777378,3833297,0.985412,EXR-KJENS10CSF9902-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9902_CONTROL_CSF_fastq,99_02_CSF,4/4,70,,2.0,no,no,no,1.5,2.0,2.0,1.0,1.75,8.25,sparse,0.0,0.0,0.0,0.0,0.0,0.0,I,criteria not met,No Lewy bodies,none,SRR1568712,female
175,sample_SAMPLE_0204_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0204_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0204_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0204 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1498903,1710381,0.876356,EXR-KJENS10SER0204-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0204_CONTROL_SER_fastq,02_04_SER,3/3,80,,2.0,no,no,no,1.25,0.5,0.0,0.0,0.0,1.75,moderate,0.0,0.0,0.0,1.5,2.0,3.5,III,criteria not met,No Lewy bodies,none,SRR1568394,female
176,sample_SAMPLE_0652_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0652_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0652_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0652 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,537940,863655,0.622864,EXR-KJENS10SER0652-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0652_AD_SER_fastq,06_52_SER,3/3,78,8.0,3.33,no,no,no,2.0,2.5,1.5,0.0,2.5,8.5,moderate,1.5,1.5,1.5,0.0,0.5,5.0,V,high,No Lewy bodies,severe,SRR1568515,female
177,sample_SAMPLE_9631_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9631_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9631_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9631 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,2640915,2800090,0.943154,EXR-KJENS10CSF9631-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9631_AD_CSF_fastq,96_31_CSF,3/3,88,5.0,2.0,no,no,no,3.0,3.0,3.0,2.0,2.0,13.0,frequent,1.0,2.3,2.0,1.0,3.0,9.3,IV,intermediate,No Lewy bodies,,SRR1568651,male
178,sample_SAMPLE_1022_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_1022_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_1022_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,1022 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,8770864,8958808,0.979021,EXR-KJENS10CSF1022-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_1022_CONTROL_CSF_fastq,10_22_CSF,3/3,59,,3.15,no,no,no,0.0,1.0,0.0,0.0,0.5,1.5,zero,0.0,0.0,0.0,0.0,0.5,0.5,I,criteria not met,No Lewy bodies,none,SRR1568612,female
179,sample_SAMPLE_9917_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9917_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9917_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9917 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2563581,2683083,0.955461,EXR-KJENS10SER9917-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9917_PD_SER_fastq,99_17_SER,3/3,83,21.0,12.0,no,no,no,0.5,0.0,1.0,0.0,0.0,1.5,sparse,0.0,0.5,0.0,1.5,2.25,4.25,III,criteria not met,Limbic type,severe,SRR1568725,female
180,sample_SAMPLE_0417_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0417_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0417_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0417 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1071137,1084530,0.987651,EXR-KJENS10CSF0417-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0417_PD_CSF_fastq,04_17_CSF,2/3,83,7.0,2.0,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.25,0.0,2.0,2.0,4.25,III,criteria not met,Brainstem predominant type,none,SRR1568452,male
181,sample_SAMPLE_0766_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0766_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0766_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0766 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,8811220,8925169,0.987233,EXR-KJENS10CSF0766-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0766_PD_CSF_fastq,07_66_CSF,3/3,75,21.0,2.25,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,1.5,2.0,3.5,III,criteria not met,Neocortical type,severe,SRR1568548,male
182,sample_SAMPLE_0954_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0954_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0954_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0954 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,10544662,10729174,0.982803,EXR-KJENS10CSF0954-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0954_PD_CSF_fastq,09_54_CSF,3/3,82,13.0,4.75,no,no,yes,3.0,3.0,3.0,2.0,3.0,14.0,frequent,2.5,3.0,3.0,3.0,3.0,14.5,V,high,Neocortical type,severe,SRR1568604,female
183,sample_SAMPLE_0137_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0137_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0137_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0137 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1456465,1502103,0.969617,EXR-KJENS10SER0137-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0137_CONTROL_SER_fastq,01_37_SER,3/4,88,,3.0,no,no,no,0.0,0.25,0.0,0.0,0.0,0.25,zero,0.0,0.0,0.0,1.0,1.0,2.0,II,criteria not met,No Lewy bodies,none,SRR1568381,female
184,sample_SAMPLE_1016_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_1016_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_1016_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,1016 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,3026729,3104443,0.974967,EXR-KJENS10SER1016-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_1016_AD_SER_fastq,10_16_SER,3/3,68,8.0,4.16,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,No Lewy bodies,mild,SRR1568611,female
185,sample_SAMPLE_0321_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0321_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0321_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0321 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,2995881,3081347,0.972263,EXR-KJENS10CSF0321-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0321_AD_CSF_fastq,03_21_CSF,3/3,84,15.0,1.83,no,no,no,3.0,3.0,3.0,2.5,3.0,14.5,frequent,3.0,3.0,3.0,2.75,3.0,14.75,VI,high,No Lewy bodies,none,SRR1568422,female
186,sample_SAMPLE_0710_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0710_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0710_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0710 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,2671003,2706821,0.986768,EXR-KJENS10CSF0710-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0710_CONTROL_CSF_fastq,07_10_CSF,3/3,90,,4.25,no,no,no,2.5,3.0,2.0,0.5,2.5,10.5,frequent,0.0,0.0,0.0,2.5,2.5,5.0,III,criteria not met,No Lewy bodies,none,SRR1568526,female
187,sample_SAMPLE_9909_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9909_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9909_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9909 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,5968461,6095761,0.979117,EXR-KJENS10CSF9909-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9909_PD_CSF_fastq,99_09_CSF,3/3,77,21.0,2.66,no,no,no,0.0,1.0,0.5,0.0,0.0,1.5,zero,0.0,0.5,0.0,1.0,1.5,3.0,II,criteria not met,Limbic type,severe,SRR1568716,female
188,sample_SAMPLE_0422_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0422_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0422_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0422 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2342997,2573670,0.910372,EXR-KJENS10SER0422-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0422_AD_SER_fastq,04_22_SER,3/4,80,8.0,7.0,no,no,no,2.5,3.0,2.5,1.5,2.75,12.25,frequent,2.5,3.0,2.5,3.0,3.0,14.0,V,high,No Lewy bodies,mild,SRR1568455,male
189,sample_SAMPLE_9748_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9748_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9748_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9748 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1628965,1641179,0.992558,EXR-KJENS10CSF9748-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9748_AD_CSF_fastq,97_48_CSF,3/4,90,12.0,3.5,no,no,no,2.3,3.0,3.0,2.5,2.5,13.3,frequent,2.0,3.0,3.0,3.0,3.0,14.0,VI,high,LB pathology unspecified or not further assessed,severe,SRR1568677,female
190,sample_SAMPLE_0957_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0957_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0957_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0957 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,FAIL,1055695,3626343,0.291118,EXR-KJENS10SER0957-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0957_CONTROL_SER_fastq,09_57_SER,2/2,80,,3.5,no,no,no,0.0,1.5,0.5,0.0,2.5,4.5,sparse,0.0,0.5,0.0,2.0,2.5,5.0,III,criteria not met,No Lewy bodies,none,SRR1568606,male
191,sample_SAMPLE_1029_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_1029_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_1029_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,1029 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1021985,1036197,0.986284,EXR-KJENS10SER1029-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_1029_PD_SER_fastq,10_29_SER,3/4,73,11.0,2.5,no,no,no,3.0,3.0,3.0,2.5,3.0,14.5,frequent,0.0,0.5,0.0,3.0,3.0,6.5,IV,intermediate,Neocortical type,severe,SRR1568619,male
192,sample_SAMPLE_9646_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9646_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9646_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9646 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,164143,262426,0.625483,EXR-KJENS10SER9646-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9646_AD_SER_fastq,96_46_SER,4/4,87,9.0,2.0,no,no,no,3.0,3.0,2.0,3.0,3.0,14.0,moderate,1.0,2.0,1.0,3.0,3.0,10.0,IV,intermediate,No Lewy bodies,mild,SRR1568656,male
193,sample_SAMPLE_0526_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0526_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0526_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0526 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,3354575,3405518,0.985041,EXR-KJENS10SER0526-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0526_PD_SER_fastq,05_26_SER,3/3,73,18.0,7.16,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,0.0,1.0,1.0,I,criteria not met,Limbic type,moderate,SRR1568487,male
194,sample_SAMPLE_0333_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0333_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0333_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0333 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,8084957,8187343,0.987495,EXR-KJENS10CSF0333-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0333_AD_CSF_fastq,03_33_CSF,2/4,74,12.0,2.83,no,no,no,3.0,3.0,3.0,2.0,3.0,14.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,No Lewy bodies,moderate,SRR1568434,female
195,sample_SAMPLE_9611_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9611_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9611_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9611 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,5020122,5140524,0.976578,EXR-KJENS10CSF9611-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9611_AD_CSF_fastq,96_11_CSF,3/3,83,6.0,2.83,no,no,no,3.0,3.0,3.0,2.0,2.0,13.0,frequent,1.3,2.0,2.5,3.0,3.0,11.8,VI,high,,,SRR1568640,male
196,sample_SAMPLE_9721_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9721_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9721_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9721 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3168219,3275837,0.967148,EXR-KJENS10CSF9721-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9721_AD_CSF_fastq,97_21_CSF,3/4,81,7.0,1.75,no,no,no,3.0,2.75,3.0,2.0,2.25,13.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,No Lewy bodies,mild,SRR1568663,male
197,sample_SAMPLE_1037_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_1037_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_1037_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,1037 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,7074968,7169262,0.986847,EXR-KJENS10CSF1037-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_1037_PD_CSF_fastq,10_37_CSF,3/3,84,,5.0,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.5,0.0,2.0,3.0,5.5,IV,criteria not met,Limbic type,severe,SRR1568624,female
198,sample_SAMPLE_0708_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0708_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0708_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0708 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2292823,2391860,0.958594,EXR-KJENS10SER0708-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0708_AD_SER_fastq,07_08_SER,3/4,70,5.0,3.5,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,No Lewy bodies,,SRR1568525,female
199,sample_SAMPLE_0462_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0462_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0462_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0462 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1626430,1644020,0.989301,EXR-KJENS10CSF0462-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0462_CONTROL_CSF_fastq,04_62_CSF,3/3,86,,1.5,no,no,no,1.0,2.0,1.0,0.0,2.0,6.0,moderate,0.0,0.0,0.0,2.5,2.5,5.0,IV,criteria not met,No Lewy bodies,none,SRR1568469,female
200,sample_SAMPLE_9951_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9951_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9951_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9951 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1042564,1094248,0.952768,EXR-KJENS10SER9951-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9951_PD_SER_fastq,99_51_SER,3/4,73,17.0,4.0,no,no,no,3.0,3.0,3.0,0.0,1.75,10.75,moderate,0.0,0.25,0.0,0.0,2.0,2.25,II,intermediate,Neocortical type,severe,SRR1568746,male
201,sample_SAMPLE_9815_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9815_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9815_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9815 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,13739282,14028145,0.979408,EXR-KJENS10CSF9815-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9815_PD_CSF_fastq,98_15_CSF,2/3,88,1.0,2.66,no,no,no,2.25,2.0,1.5,0.0,1.0,6.75,moderate,0.0,0.25,0.0,2.0,2.0,4.25,III,intermediate,Neocortical type,mild,SRR1568691,male
202,sample_SAMPLE_0615_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0615_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0615_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0615 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,2817354,2864112,0.983675,EXR-KJENS10CSF0615-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0615_CONTROL_CSF_fastq,06_15_CSF,2/3,87,,2.5,no,no,no,1.5,1.5,1.5,0.0,0.0,4.5,moderate,0.0,0.25,0.0,1.5,2.5,4.25,III,criteria not met,No Lewy bodies,mild,SRR1568497,female
203,sample_SAMPLE_0612_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0612_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0612_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0612 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,7601606,7694574,0.987918,EXR-KJENS10CSF0612-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0612_AD_CSF_fastq,06_12_CSF,3/4,74,8.0,4.0,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,No Lewy bodies,mild,SRR1568495,female
204,sample_SAMPLE_0333_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0333_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0333_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0333 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,FAIL,1434013,7169196,0.200024,EXR-KJENS10SER0333-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0333_AD_SER_fastq,03_33_SER,2/4,74,12.0,2.83,no,no,no,3.0,3.0,3.0,2.0,3.0,14.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,No Lewy bodies,moderate,SRR1568435,female
205,sample_SAMPLE_0302_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0302_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0302_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0302 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2841169,3268556,0.869243,EXR-KJENS10SER0302-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0302_AD_SER_fastq,03_02_SER,3/4,76,2.0,4.5,no,no,no,2.5,2.5,2.5,1.5,1.75,10.75,frequent,1.5,2.5,2.5,3.0,3.0,12.5,V,high,No Lewy bodies,mild,SRR1568409,male
206,sample_SAMPLE_0146_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0146_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0146_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0146 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3960354,4047460,0.978479,EXR-KJENS10CSF0146-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0146_CONTROL_CSF_fastq,01_46_CSF,3/3,90,,3.0,no,no,no,1.0,2.0,1.0,1.0,1.5,6.5,sparse,0.0,1.0,0.0,1.5,2.0,4.5,III,criteria not met,No Lewy bodies,moderate,SRR1568386,female
207,sample_SAMPLE_0773_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0773_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0773_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0773 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,5185490,5301350,0.978145,EXR-KJENS10CSF0773-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0773_CONTROL_CSF_fastq,07_73_CSF,3/4,76,,4.0,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,0.0,0.5,0.5,I,criteria not met,No Lewy bodies,mild,SRR1568550,female
208,sample_SAMPLE_9649_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9649_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9649_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9649 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,9860206,9951230,0.990853,EXR-KJENS10SER9649-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9649_PD_SER_fastq,96_49_SER,3/3,87,0.0,2.0,no,no,no,2.5,2.0,2.5,1.0,0.0,8.0,sparse,0.0,0.0,0.0,1.0,2.0,3.0,II,criteria not met,LB pathology unspecified or not further assessed,moderate,SRR1568658,female
209,sample_SAMPLE_0888_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0888_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0888_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0888 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2437043,2579196,0.944885,EXR-KJENS10SER0888-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0888_CONTROL_SER_fastq,08_88_SER,3/3,65,,3.5,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,0.5,0.5,1.0,I,criteria not met,No Lewy bodies,none,SRR1568584,male
210,sample_SAMPLE_0722_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0722_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0722_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0722 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3069662,3177490,0.966065,EXR-KJENS10CSF0722-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0722_PD_CSF_fastq,07_22_CSF,3/4,81,6.0,3.5,no,yes,no,1.0,1.5,2.5,0.0,0.0,5.0,sparse,0.0,0.0,0.0,1.5,2.0,3.5,III,low,Limbic type,moderate,SRR1568531,female
211,sample_SAMPLE_9540_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9540_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9540_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9540 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,15447777,15755468,0.980471,EXR-KJENS10CSF9540-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9540_CONTROL_CSF_fastq,95_40_CSF,3/3,74,,2.5,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.5,1.0,0.0,1.0,1.0,3.5,II,criteria not met,No Lewy bodies,none,SRR1568635,male
212,sample_SAMPLE_0521_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0521_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0521_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0521 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,200239,393505,0.50886,EXR-KJENS10SER0521-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0521_CONTROL_SER_fastq,05_21_SER,3/3,91,7.0,2.5,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,1.0,0.0,3.0,3.0,7.0,IV,criteria not met,No Lewy bodies,mild,SRR1568485,male
213,sample_SAMPLE_9925_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9925_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_9925_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9925 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,5151923,5540596,0.92985,EXR-KJENS10SER9925-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9925_CONTROL_SER_fastq,99_25_SER,3/3,76,,2.75,no,no,no,1.6,1.0,2.0,0.0,0.0,4.6,moderate,0.0,0.0,0.0,0.0,0.0,0.0,I,criteria not met,No Lewy bodies,none,SRR1568728,female
214,sample_SAMPLE_9925_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9925_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9925_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9925 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3826733,3874428,0.98769,EXR-KJENS10CSF9925-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9925_CONTROL_CSF_fastq,99_25_CSF,3/3,76,,2.75,no,no,no,1.6,1.0,2.0,0.0,0.0,4.6,moderate,0.0,0.0,0.0,0.0,0.0,0.0,I,criteria not met,No Lewy bodies,none,SRR1568727,female
215,sample_SAMPLE_0829_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0829_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0829_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0829 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,6651824,6843529,0.971987,EXR-KJENS10CSF0829-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0829_AD_CSF_fastq,08_29_CSF,3/3,90,1.0,3.75,no,no,no,2.5,2.5,2.5,1.0,3.0,11.5,frequent,0.0,0.0,0.0,1.5,2.0,3.5,III,intermediate,LB pathology unspecified or not further assessed,mild,SRR1568556,male
216,sample_SAMPLE_0837_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0837_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0837_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0837 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2614454,4471074,0.584749,EXR-KJENS10SER0837-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0837_AD_SER_fastq,08_37_SER,2/3,87,6.0,2.5,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,2.5,3.0,3.0,3.0,3.0,14.5,VI,high,No Lewy bodies,mild,SRR1568562,male
217,sample_SAMPLE_9631_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9631_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9631_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9631 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,504157,780799,0.645694,EXR-KJENS10SER9631-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9631_AD_SER_fastq,96_31_SER,3/3,88,5.0,2.0,no,no,no,3.0,3.0,3.0,2.0,2.0,13.0,frequent,1.0,2.3,2.0,1.0,3.0,9.3,IV,intermediate,No Lewy bodies,,SRR1568652,male
218,sample_SAMPLE_0632_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0632_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0632_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0632 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2451569,2496326,0.982071,EXR-KJENS10SER0632-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0632_CONTROL_SER_fastq,06_32_SER,3/3,77,,3.0,no,no,no,3.0,2.5,3.0,0.5,2.5,11.5,frequent,0.0,0.0,0.0,0.5,1.5,2.0,II,criteria not met,No Lewy bodies,none,SRR1568507,female
219,sample_SAMPLE_0129_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0129_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0129_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0129 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,4311497,4493367,0.959525,EXR-KJENS10SER0129-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0129_PD_SER_fastq,01_29_SER,3/4,80,10.0,3.33,no,no,no,2.0,2.0,2.5,1.0,2.25,9.75,moderate,0.0,0.0,0.0,1.5,2.25,3.75,III,intermediate,Neocortical type,severe,SRR1568379,male
220,sample_SAMPLE_0627_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0627_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0627_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0627 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,2983538,3006080,0.992501,EXR-KJENS10CSF0627-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0627_CONTROL_CSF_fastq,06_27_CSF,3/3,78,,5.25,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.5,0.0,0.5,1.5,2.5,II,criteria not met,No Lewy bodies,mild,SRR1568505,male
221,sample_SAMPLE_9539_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9539_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_9539_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9539 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,366705,514708,0.712452,EXR-KJENS10SER9539-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9539_CONTROL_SER_fastq,95_39_SER,3/3,68,,2.0,no,no,no,1.6,2.5,2.0,2.5,3.0,11.6,sparse,0.0,0.0,0.0,1.5,1.0,2.5,III,criteria not met,,none,SRR1568634,male
222,sample_SAMPLE_0431_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0431_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0431_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0431 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,186838,295602,0.632059,EXR-KJENS10SER0431-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0431_CONTROL_SER_fastq,04_31_SER,3/4,82,,3.0,no,no,no,3.0,3.0,3.0,2.0,3.0,14.0,frequent,0.5,3.0,1.5,3.0,3.0,11.0,IV,criteria not met,No Lewy bodies,none,SRR1568462,male
223,sample_SAMPLE_0635_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0635_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0635_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0635 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,FAIL,1437456,3870624,0.371376,EXR-KJENS10SER0635-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0635_CONTROL_SER_fastq,06_35_SER,3/3,89,,3.33,no,no,no,1.5,1.0,2.5,0.0,1.5,6.5,moderate,0.0,0.0,0.0,1.5,2.0,3.5,III,criteria not met,No Lewy bodies,moderate,SRR1568509,male
224,sample_SAMPLE_0520_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0520_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0520_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0520 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,6932798,7051334,0.98319,EXR-KJENS10CSF0520-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0520_CONTROL_CSF_fastq,05_20_CSF,3/3,75,3.0,4.33,no,no,no,3.0,3.0,3.0,2.0,3.0,14.0,frequent,0.5,1.0,0.5,3.0,3.0,8.0,IV,criteria not met,No Lewy bodies,none,SRR1568482,male
225,sample_SAMPLE_0651_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0651_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0651_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0651 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,8101038,8174084,0.991064,EXR-KJENS10CSF0651-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0651_PD_CSF_fastq,06_51_CSF,2/3,87,9.0,2.16,no,no,no,0.5,1.0,0.5,0.0,0.0,2.0,sparse,0.0,0.0,0.0,0.5,1.0,1.5,I,criteria not met,Limbic type,severe,SRR1568512,female
226,sample_SAMPLE_0339_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0339_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0339_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0339 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,FAIL,98567,259692,0.379553,EXR-KJENS10SER0339-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0339_CONTROL_SER_fastq,03_39_SER,3/3,86,,2.75,no,no,no,2.5,2.0,3.0,0.0,1.25,8.75,moderate,0.0,0.75,0.0,0.25,0.75,1.75,II,criteria not met,No Lewy bodies,none,SRR1568442,male
227,sample_SAMPLE_0806_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0806_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0806_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0806 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,4459462,4536874,0.982937,EXR-KJENS10CSF0806-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0806_AD_CSF_fastq,08_06_CSF,3/4,79,5.0,2.66,no,no,no,2.5,2.5,2.0,2.0,2.5,11.5,moderate,0.0,0.0,0.0,1.0,1.0,2.0,II,low,No Lewy bodies,none,SRR1568552,male
228,sample_SAMPLE_0310_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0310_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0310_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0310 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1325851,1605280,0.825931,EXR-KJENS10SER0310-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0310_CONTROL_SER_fastq,03_10_SER,3/4,89,5.0,1.5,no,no,no,3.0,2.5,2.5,2.0,1.75,11.75,moderate,0.0,1.25,0.0,2.75,3.0,7.0,IV,criteria not met,No Lewy bodies,none,SRR1568414,male
229,sample_SAMPLE_0773_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0773_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0773_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0773 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,5468508,5907443,0.925698,EXR-KJENS10SER0773-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0773_CONTROL_SER_fastq,07_73_SER,3/4,76,,4.0,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,0.0,0.5,0.5,I,criteria not met,No Lewy bodies,mild,SRR1568551,female
230,sample_SAMPLE_9629_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9629_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9629_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9629 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1565618,1717173,0.911742,EXR-KJENS10SER9629-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9629_AD_SER_fastq,96_29_SER,3/4,77,1.0,2.5,no,no,no,3.0,2.5,3.0,2.0,2.0,12.5,moderate,1.0,2.0,1.5,3.0,3.0,10.5,VI,high,No Lewy bodies,none,SRR1568648,male
231,sample_SAMPLE_9964_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9964_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9964_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9964 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,9028230,9576202,0.942778,EXR-KJENS10SER9964-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9964_AD_SER_fastq,99_64_SER,3/4,79,10.0,1.5,no,no,no,3.0,3.0,3.0,2.5,2.5,14.0,frequent,2.66,3.0,3.0,3.0,3.0,14.66,VI,high,No Lewy bodies,severe,SRR1568756,female
232,sample_SAMPLE_0405_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0405_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0405_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0405 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,567597,945450,0.600346,EXR-KJENS10SER0405-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0405_CONTROL_SER_fastq,04_05_SER,3/3,82,,2.25,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,1.5,2.0,3.5,II,criteria not met,No Lewy bodies,none,SRR1568449,female
233,sample_SAMPLE_0454_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0454_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0454_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0454 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3503952,3646518,0.960904,EXR-KJENS10CSF0454-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0454_AD_CSF_fastq,04_54_CSF,3/3,75,7.0,3.0,no,no,no,3.0,3.0,3.0,1.5,2.75,13.25,frequent,3.0,3.0,3.0,3.0,3.0,15.0,V,high,LB pathology unspecified or not further assessed,none,SRR1568467,male
234,sample_SAMPLE_0023_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0023_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0023_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0023 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,502929,616419,0.815888,EXR-KJENS10SER0023-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0023_PD_SER_fastq,00_23_SER,4/4,82,10.0,2.83,no,no,no,2.5,2.5,2.5,2.0,2.0,11.5,moderate,1.0,1.0,0.5,2.25,2.75,7.5,IV,intermediate,Neocortical type,severe,SRR1568363,female
235,sample_SAMPLE_9536_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9536_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_9536_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9536 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2334582,2441150,0.956345,EXR-KJENS10SER9536-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9536_CONTROL_SER_fastq,95_36_SER,3/3,92,,1.16,no,no,no,3.0,2.5,3.0,1.0,1.0,10.5,moderate,0.3,0.0,0.0,3.0,3.0,6.3,III,criteria not met,LB pathology unspecified or not further assessed,none,SRR1568633,female
236,sample_SAMPLE_0764_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0764_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0764_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0764 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,474065,519534,0.912481,EXR-KJENS10SER0764-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0764_AD_SER_fastq,07_64_SER,2/3,91,19.0,7.0,no,no,no,2.0,2.0,2.5,0.0,0.0,6.5,moderate,0.0,0.0,0.0,0.0,2.5,2.5,II,low,No Lewy bodies,mild,SRR1568547,female
237,sample_SAMPLE_9910_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9910_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9910_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9910 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,FAIL,424911,1684621,0.252229,EXR-KJENS10SER9910-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9910_AD_SER_fastq,99_10_SER,3/4,74,7.0,2.0,no,no,no,2.6,3.0,3.0,2.5,2.5,13.6,frequent,3.0,3.0,3.0,3.0,3.0,15.0,V,high,No Lewy bodies,moderate,SRR1568719,female
238,sample_SAMPLE_0210_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0210_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0210_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0210 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,689574,699309,0.986079,EXR-KJENS10CSF0210-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0210_PD_CSF_fastq,02_10_CSF,3/3,71,12.0,3.5,no,no,no,2.75,2.25,2.5,1.5,2.25,11.25,moderate,0.0,0.5,0.0,0.5,2.0,3.0,III,intermediate,Neocortical type,severe,SRR1568398,male
239,sample_SAMPLE_9905_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9905_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9905_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9905 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3817721,3846108,0.992619,EXR-KJENS10CSF9905-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9905_PD_CSF_fastq,99_05_CSF,3/3,83,1.0,2.5,no,no,no,2.0,2.5,2.0,1.5,2.0,10.0,frequent,0.0,0.5,0.0,2.5,2.5,5.5,IV,intermediate,Limbic type,severe,SRR1568714,female
240,sample_SAMPLE_0950_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0950_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0950_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0950 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3465703,3517590,0.985249,EXR-KJENS10CSF0950-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0950_CONTROL_CSF_fastq,09_50_CSF,3/3,53,,3.66,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,0.5,0.5,1.0,I,criteria not met,No Lewy bodies,none,SRR1568602,male
241,sample_SAMPLE_0417_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0417_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0417_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0417 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,18159281,18517840,0.980637,EXR-KJENS10SER0417-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0417_PD_SER_fastq,04_17_SER,2/3,83,7.0,2.0,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.25,0.0,2.0,2.0,4.25,III,criteria not met,Brainstem predominant type,none,SRR1568453,male
242,sample_SAMPLE_0302_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0302_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0302_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0302 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,4727178,4923192,0.960186,EXR-KJENS10CSF0302-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0302_AD_CSF_fastq,03_02_CSF,3/4,76,2.0,4.5,no,no,no,2.5,2.5,2.5,1.5,1.75,10.75,frequent,1.5,2.5,2.5,3.0,3.0,12.5,V,high,No Lewy bodies,mild,SRR1568408,male
243,sample_SAMPLE_0146_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0146_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0146_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0146 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2353374,2366547,0.994434,EXR-KJENS10SER0146-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0146_CONTROL_SER_fastq,01_46_SER,3/3,90,,3.0,no,no,no,1.0,2.0,1.0,1.0,1.5,6.5,sparse,0.0,1.0,0.0,1.5,2.0,4.5,III,criteria not met,No Lewy bodies,moderate,SRR1568387,female
244,sample_SAMPLE_0920_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0920_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0920_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0920 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1694363,1720216,0.984971,EXR-KJENS10CSF0920-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0920_CONTROL_CSF_fastq,09_20_CSF,3/3,99,,3.5,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.5,0.0,1.0,2.0,3.5,III,criteria not met,No Lewy bodies,none,SRR1568589,female
245,sample_SAMPLE_9822_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9822_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9822_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9822 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,2251443,2272335,0.990806,EXR-KJENS10CSF9822-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9822_CONTROL_CSF_fastq,98_22_CSF,3/3,90,,2.5,no,no,no,2.7,2.3,2.0,1.0,0.0,8.0,moderate,0.0,0.0,0.0,1.0,1.0,2.0,III,criteria not met,No Lewy bodies,mild,SRR1568697,male
246,sample_SAMPLE_9830_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9830_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9830_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9830 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,806466,894744,0.901337,EXR-KJENS10SER9830-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9830_AD_SER_fastq,98_30_SER,3/4,86,5.0,2.5,no,no,no,2.75,2.5,3.0,2.5,2.5,13.25,frequent,1.0,2.0,1.5,1.5,2.75,8.75,V,high,No Lewy bodies,moderate,SRR1568705,female
247,sample_SAMPLE_0322_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0322_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0322_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0322 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,5201783,5249776,0.990858,EXR-KJENS10SER0322-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0322_PD_SER_fastq,03_22_SER,3/3,86,11.0,10.5,no,no,no,2.5,2.0,2.5,1.0,2.0,10.0,moderate,1.0,1.0,1.0,2.5,3.0,8.5,IV,criteria not met,Limbic type,severe,SRR1568425,female
248,sample_SAMPLE_0325_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0325_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0325_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0325 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,811745,956921,0.848288,EXR-KJENS10SER0325-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0325_PD_SER_fastq,03_25_SER,3/3,78,19.0,2.5,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,1.5,0.25,1.75,III,criteria not met,Brainstem predominant type,severe,SRR1568427,male
249,sample_SAMPLE_0116_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0116_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0116_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0116 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2076627,2275820,0.912474,EXR-KJENS10SER0116-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0116_AD_SER_fastq,01_16_SER,3/4,87,12.0,3.0,no,no,no,3.0,3.0,3.0,2.0,2.25,13.25,frequent,2.5,2.75,1.0,3.0,3.0,12.25,V,high,No Lewy bodies,mild,SRR1568369,male
250,sample_SAMPLE_0627_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0627_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0627_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0627 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,3977592,4031139,0.986717,EXR-KJENS10SER0627-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0627_CONTROL_SER_fastq,06_27_SER,3/3,78,,5.25,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.5,0.0,0.5,1.5,2.5,II,criteria not met,No Lewy bodies,mild,SRR1568506,male
251,sample_SAMPLE_0415_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0415_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0415_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0415 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,FAIL,1031292,2571302,0.401078,EXR-KJENS10SER0415-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0415_PD_SER_fastq,04_15_SER,3/4,89,,2.66,no,no,no,2.5,2.5,3.0,0.25,1.25,9.5,moderate,0.0,0.0,0.0,1.5,1.75,3.25,III,criteria not met,Brainstem predominant type,mild,SRR1568451,male
252,sample_SAMPLE_9928_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9928_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9928_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9928 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,931907,971717,0.959031,EXR-KJENS10SER9928-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9928_AD_SER_fastq,99_28_SER,3/4,80,3.0,3.0,no,no,no,2.5,2.5,3.0,3.0,3.0,14.0,moderate,0.0,0.5,0.0,3.0,3.0,6.5,IV,intermediate,No Lewy bodies,moderate,SRR1568734,male
253,sample_SAMPLE_0215_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0215_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0215_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0215 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,206292,238415,0.865264,EXR-KJENS10SER0215-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0215_PD_SER_fastq,02_15_SER,3/3,78,16.0,3.5,no,no,no,2.5,2.5,3.0,1.0,2.75,11.75,sparse,0.0,0.25,0.0,1.5,3.0,4.75,III,low,Neocortical type,severe,SRR1568401,female
254,sample_SAMPLE_0754_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0754_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0754_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0754 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,5183304,5319114,0.974468,EXR-KJENS10CSF0754-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0754_AD_CSF_fastq,07_54_CSF,3/3,82,11.0,4.0,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,No Lewy bodies,mild,SRR1568539,female
255,sample_SAMPLE_0711_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0711_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0711_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0711 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,3937095,4574517,0.860658,EXR-KJENS10SER0711-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0711_CONTROL_SER_fastq,07_11_SER,3/4,75,,2.75,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,2.0,3.0,5.0,III,criteria not met,No Lewy bodies,none,SRR1568528,female
256,sample_SAMPLE_0840_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0840_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0840_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0840 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,4069207,4321979,0.941515,EXR-KJENS10CSF0840-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0840_CONTROL_CSF_fastq,08_40_CSF,3/4,76,,2.33,no,no,no,1.0,1.0,2.5,0.0,1.0,5.5,sparse,0.0,0.0,0.0,0.0,0.0,0.0,I,criteria not met,No Lewy bodies,,SRR1568563,male
257,sample_SAMPLE_0045_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0045_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0045_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0045 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,4148257,4229486,0.980795,EXR-KJENS10CSF0045-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0045_PD_CSF_fastq,00_45_CSF,3/3,70,12.0,1.83,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,1.0,2.25,3.25,III,not AD,Limbic type,severe,SRR1568366,male
258,sample_SAMPLE_0845_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0845_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0845_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0845 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,FAIL,92545,97260,0.951522,EXR-KJENS10SER0845-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0845_AD_SER_fastq,08_45_SER,3/4,78,5.0,2.25,no,no,no,3.0,3.0,3.0,2.0,3.0,14.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,No Lewy bodies,mild,SRR1568566,male
259,sample_SAMPLE_9951_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9951_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9951_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9951 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1689778,1733094,0.975007,EXR-KJENS10CSF9951-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9951_PD_CSF_fastq,99_51_CSF,3/4,73,17.0,4.0,no,no,no,3.0,3.0,3.0,0.0,1.75,10.75,moderate,0.0,0.25,0.0,0.0,2.0,2.25,II,intermediate,Neocortical type,severe,SRR1568745,male
260,sample_SAMPLE_0129_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0129_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0129_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0129 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1388919,1407550,0.986764,EXR-KJENS10CSF0129-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0129_PD_CSF_fastq,01_29_CSF,3/4,80,10.0,3.33,no,no,no,2.0,2.0,2.5,1.0,2.25,9.75,moderate,0.0,0.0,0.0,1.5,2.25,3.75,III,intermediate,Neocortical type,severe,SRR1568378,male
261,sample_SAMPLE_0118_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0118_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0118_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0118 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,2877344,2973079,0.967799,EXR-KJENS10CSF0118-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0118_AD_CSF_fastq,01_18_CSF,3/3,86,21.0,3.0,no,no,no,3.0,3.0,3.0,3.0,2.25,14.25,moderate,1.0,1.75,2.5,3.0,3.0,11.25,V,high,No Lewy bodies,severe,SRR1568370,male
262,sample_SAMPLE_9810_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9810_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9810_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9810 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,2117855,2161001,0.980034,EXR-KJENS10CSF9810-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9810_AD_CSF_fastq,98_10_CSF,3/4,82,7.0,2.25,no,no,no,2.5,3.0,3.0,2.0,2.5,13.0,frequent,2.0,3.0,2.0,3.0,3.0,13.0,V,high,LB pathology unspecified or not further assessed,mild,SRR1568687,male
263,sample_SAMPLE_0454_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0454_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0454_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0454 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,235168,329000,0.714796,EXR-KJENS10SER0454-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0454_AD_SER_fastq,04_54_SER,3/3,75,7.0,3.0,no,no,no,3.0,3.0,3.0,1.5,2.75,13.25,frequent,3.0,3.0,3.0,3.0,3.0,15.0,V,high,LB pathology unspecified or not further assessed,none,SRR1568468,male
264,sample_SAMPLE_0339_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0339_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0339_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0339 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,14763605,15436961,0.95638,EXR-KJENS10CSF0339-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0339_CONTROL_CSF_fastq,03_39_CSF,3/3,86,,2.75,no,no,no,2.5,2.0,3.0,0.0,1.25,8.75,moderate,0.0,0.75,0.0,0.25,0.75,1.75,II,criteria not met,No Lewy bodies,none,SRR1568441,male
265,sample_SAMPLE_0920_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0920_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0920_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0920 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,910780,925369,0.984234,EXR-KJENS10SER0920-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0920_CONTROL_SER_fastq,09_20_SER,3/3,99,,3.5,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.5,0.0,1.0,2.0,3.5,III,criteria not met,No Lewy bodies,none,SRR1568590,female
266,sample_SAMPLE_0655_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0655_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0655_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0655 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,264896,359802,0.736227,EXR-KJENS10SER0655-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0655_PD_SER_fastq,06_55_SER,2/3,83,15.0,4.33,no,no,yes,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.5,0.0,0.0,0.0,0.0,0.5,0,criteria not met,Limbic type,severe,SRR1568517,male
267,sample_SAMPLE_0431_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0431_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0431_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0431 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,5181363,5227462,0.991181,EXR-KJENS10CSF0431-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0431_CONTROL_CSF_fastq,04_31_CSF,3/4,82,,3.0,no,no,no,3.0,3.0,3.0,2.0,3.0,14.0,frequent,0.5,3.0,1.5,3.0,3.0,11.0,IV,criteria not met,No Lewy bodies,none,SRR1568461,male
268,sample_SAMPLE_0806_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0806_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0806_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0806 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,11974419,12126683,0.987444,EXR-KJENS10SER0806-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0806_AD_SER_fastq,08_06_SER,3/4,79,5.0,2.66,no,no,no,2.5,2.5,2.0,2.0,2.5,11.5,moderate,0.0,0.0,0.0,1.0,1.0,2.0,II,low,No Lewy bodies,none,SRR1568553,male
269,sample_SAMPLE_0855_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0855_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0855_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0855 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,10708529,10775262,0.993807,EXR-KJENS10SER0855-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0855_CONTROL_SER_fastq,08_55_SER,3/3,71,,3.0,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,0.0,0.0,0.0,I,criteria not met,No Lewy bodies,none,SRR1568570,male
270,sample_SAMPLE_0942_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0942_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0942_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0942 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,6909694,7045373,0.980742,EXR-KJENS10CSF0942-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0942_AD_CSF_fastq,09_42_CSF,3/3,85,5.0,3.0,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,No Lewy bodies,none,SRR1568599,male
271,sample_SAMPLE_0877_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0877_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0877_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0877 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1344598,1352519,0.994144,EXR-KJENS10CSF0877-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0877_CONTROL_CSF_fastq,08_77_CSF,3/3,91,,7.25,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,2.0,2.0,4.0,IV,criteria not met,No Lewy bodies,none,SRR1568578,female
272,sample_SAMPLE_0635_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0635_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0635_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0635 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,5853578,6001069,0.975423,EXR-KJENS10CSF0635-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0635_CONTROL_CSF_fastq,06_35_CSF,3/3,89,,3.33,no,no,no,1.5,1.0,2.5,0.0,1.5,6.5,moderate,0.0,0.0,0.0,1.5,2.0,3.5,III,criteria not met,No Lewy bodies,moderate,SRR1568508,male
273,sample_SAMPLE_9915_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9915_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9915_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9915 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1359587,1377893,0.986714,EXR-KJENS10CSF9915-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9915_AD_CSF_fastq,99_15_CSF,4/4,83,8.0,2.83,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,No Lewy bodies,none,SRR1568722,male
274,sample_SAMPLE_0354_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0354_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0354_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0354 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,7450475,7529658,0.989484,EXR-KJENS10CSF0354-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0354_AD_CSF_fastq,03_54_CSF,4/4,76,4.0,4.0,no,no,no,2.5,3.0,3.0,1.5,1.75,11.75,frequent,3.0,3.0,3.0,3.0,3.0,15.0,V,high,No Lewy bodies,none,SRR1568445,male
275,sample_SAMPLE_0427_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0427_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0427_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0427 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,5329869,5711289,0.933216,EXR-KJENS10SER0427-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0427_PD_SER_fastq,04_27_SER,3/4,79,20.0,3.5,no,no,no,2.5,3.0,3.0,2.0,2.75,13.25,moderate,0.5,0.5,0.5,2.0,3.0,6.5,IV,intermediate,Neocortical type,severe,SRR1568458,female
276,sample_SAMPLE_0312_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0312_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0312_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0312 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,11730283,11808207,0.993401,EXR-KJENS10CSF0312-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0312_CONTROL_CSF_fastq,03_12_CSF,3/4,88,,7.0,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.25,0.0,1.5,1.25,3.0,III,criteria not met,No Lewy bodies,none,SRR1568415,female
277,sample_SAMPLE_9739_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9739_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9739_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9739 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,7501349,7649349,0.980652,EXR-KJENS10CSF9739-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9739_AD_CSF_fastq,97_39_CSF,3/4,78,7.0,1.75,no,no,no,3.0,3.0,3.0,2.0,2.0,13.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,No Lewy bodies,severe,SRR1568672,female
278,sample_SAMPLE_0205_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0205_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0205_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0205 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3587152,3604006,0.995324,EXR-KJENS10CSF0205-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0205_PD_CSF_fastq,02_05_CSF,3/3,86,7.0,2.5,no,no,no,2.0,1.5,1.5,0.0,1.25,6.25,moderate,0.0,1.0,0.0,1.5,2.5,5.0,III,intermediate,Limbic type,severe,SRR1568395,male
279,sample_SAMPLE_0935_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0935_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0935_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0935 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1330535,1478943,0.899653,EXR-KJENS10SER0935-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0935_CONTROL_SER_fastq,09_35_SER,3/3,38,,3.0,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,0.0,0.0,0.0,0,criteria not met,No Lewy bodies,none,SRR1568594,male
280,sample_SAMPLE_0757_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0757_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0757_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0757 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1491992,1520259,0.981406,EXR-KJENS10SER0757-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0757_AD_SER_fastq,07_57_SER,,91,10.0,2.5,no,no,no,3.0,3.0,3.0,1.0,3.0,13.0,frequent,0.5,3.0,1.5,3.0,3.0,11.0,IV,intermediate,No Lewy bodies,mild,SRR1568541,female
281,sample_SAMPLE_0742_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0742_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0742_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0742 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,2126826,2159976,0.984653,EXR-KJENS10CSF0742-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0742_AD_CSF_fastq,07_42_CSF,3/4,65,3.0,2.75,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,No Lewy bodies,none,SRR1568537,female
282,sample_SAMPLE_9963_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9963_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9963_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9963 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,11379979,11466963,0.992414,EXR-KJENS10CSF9963-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9963_PD_CSF_fastq,99_63_CSF,3/3,85,0.0,2.66,no,no,no,1.5,1.0,1.5,0.0,0.75,4.75,sparse,0.0,0.5,0.0,1.5,1.5,3.5,III,low,Limbic type,severe,SRR1568753,male
283,sample_SAMPLE_9744_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9744_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9744_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9744 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2307986,2452976,0.940892,EXR-KJENS10SER9744-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9744_AD_SER_fastq,97_44_SER,3/4,75,8.0,2.0,no,no,no,3.0,3.0,2.5,2.0,3.0,13.5,frequent,1.3,1.5,1.0,2.5,2.5,8.8,V,high,No Lewy bodies,none,SRR1568674,male
284,sample_SAMPLE_0619_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0619_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0619_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0619 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,3216347,3452774,0.931525,EXR-KJENS10SER0619-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0619_CONTROL_SER_fastq,06_19_SER,2/3,84,,4.25,no,no,no,1.5,1.5,2.0,1.0,1.0,7.0,moderate,0.0,0.25,0.0,0.5,0.5,1.25,II,criteria not met,No Lewy bodies,none,SRR1568500,male
285,sample_SAMPLE_9909_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9909_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9909_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9909 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,724567,1368486,0.529466,EXR-KJENS10SER9909-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9909_PD_SER_fastq,99_09_SER,3/3,77,21.0,2.66,no,no,no,0.0,1.0,0.5,0.0,0.0,1.5,zero,0.0,0.5,0.0,1.0,1.5,3.0,II,criteria not met,Limbic type,severe,SRR1568717,female
286,sample_SAMPLE_0354_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0354_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0354_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0354 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,FAIL,337097,1635544,0.206107,EXR-KJENS10SER0354-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0354_AD_SER_fastq,03_54_SER,4/4,76,4.0,4.0,no,no,no,2.5,3.0,3.0,1.5,1.75,11.75,frequent,3.0,3.0,3.0,3.0,3.0,15.0,V,high,No Lewy bodies,none,SRR1568446,male
287,sample_SAMPLE_0351_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0351_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0351_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0351 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,4913975,4949821,0.992758,EXR-KJENS10CSF0351-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0351_PD_CSF_fastq,03_51_CSF,3/3,70,30.0,2.33,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,0.5,1.5,2.0,II,low,Limbic type,severe,SRR1568443,male
288,sample_SAMPLE_0874_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0874_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0874_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0874 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3136011,3204091,0.978752,EXR-KJENS10CSF0874-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0874_PD_CSF_fastq,08_74_CSF,3/3,79,,3.16,no,no,no,1.5,2.0,1.5,0.0,2.5,7.5,sparse,0.0,0.5,0.0,1.0,2.0,3.5,II,criteria not met,Limbic type,severe,SRR1568576,female
289,sample_SAMPLE_9722_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9722_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9722_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9722 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,12953805,13120900,0.987265,EXR-KJENS10CSF9722-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9722_AD_CSF_fastq,97_22_CSF,3/4,81,7.0,2.5,no,no,no,2.5,2.5,2.0,2.5,2.0,11.5,frequent,1.6,2.5,1.0,3.0,3.0,11.1,V,high,No Lewy bodies,mild,SRR1568665,female
290,sample_SAMPLE_9717_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9717_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_9717_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9717 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,14219346,14292116,0.994908,EXR-KJENS10SER9717-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9717_CONTROL_SER_fastq,97_17_SER,3/3,78,,2.66,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,0.0,1.0,1.0,II,criteria not met,No Lewy bodies,moderate,SRR1568660,male
291,sample_SAMPLE_9811_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9811_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9811_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9811 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2056488,2159159,0.952449,EXR-KJENS10SER9811-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9811_PD_SER_fastq,98_11_SER,3/3,76,2.0,5.16,no,no,yes,1.0,1.5,1.5,0.0,2.0,6.0,zero,0.0,0.75,0.0,2.0,2.0,4.75,III,not AD,Brainstem predominant type,moderate,SRR1568690,male
292,sample_SAMPLE_0149_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0149_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0149_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0149 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3456599,3555884,0.972079,EXR-KJENS10CSF0149-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0149_PD_CSF_fastq,01_49_CSF,3/3,79,6.0,2.0,no,no,no,3.0,2.75,3.0,2.0,2.0,12.75,moderate,0.0,1.25,0.0,3.0,3.0,7.25,IV,intermediate,Brainstem predominant type,mild,SRR1568389,female
293,sample_SAMPLE_9822_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9822_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_9822_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9822 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1219372,1303856,0.935205,EXR-KJENS10SER9822-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9822_CONTROL_SER_fastq,98_22_SER,3/3,90,,2.5,no,no,no,2.7,2.3,2.0,1.0,0.0,8.0,moderate,0.0,0.0,0.0,1.0,1.0,2.0,III,criteria not met,No Lewy bodies,mild,SRR1568698,male
294,sample_SAMPLE_1026_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_1026_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_1026_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,1026 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,479699,492456,0.974095,EXR-KJENS10CSF1026-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_1026_CONTROL_CSF_fastq,10_26_CSF,3/3,95,2.0,2.5,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.5,0.0,3.0,3.0,6.5,III,criteria not met,No Lewy bodies,none,SRR1568614,female
295,sample_SAMPLE_9751_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9751_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_9751_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9751 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2694774,2744416,0.981912,EXR-KJENS10SER9751-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9751_CONTROL_SER_fastq,97_51_SER,3/3,84,,3.0,no,no,no,2.8,2.3,2.5,0.5,2.5,10.6,frequent,0.0,1.0,0.0,1.0,2.5,4.5,III,criteria not met,No Lewy bodies,moderate,SRR1568682,male
296,sample_SAMPLE_0623_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0623_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0623_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0623 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1515343,1542695,0.98227,EXR-KJENS10SER0623-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0623_PD_SER_fastq,06_23_SER,3/3,77,23.0,4.0,no,no,no,2.5,2.5,2.0,0.0,2.0,9.0,frequent,1.0,1.0,1.0,3.0,3.0,9.0,IV,intermediate,Limbic type,severe,SRR1568504,female
297,sample_SAMPLE_0517_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0517_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0517_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0517 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1874981,1996606,0.939084,EXR-KJENS10SER0517-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0517_PD_SER_fastq,05_17_SER,3/3,84,23.0,2.0,no,no,no,0.0,1.0,0.0,0.0,1.0,2.0,zero,0.0,0.0,0.0,0.5,1.0,1.5,II,low,Limbic type,severe,SRR1568479,female
298,sample_SAMPLE_0210_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0210_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0210_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0210 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,8590284,8770518,0.97945,EXR-KJENS10SER0210-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0210_PD_SER_fastq,02_10_SER,3/3,71,12.0,3.5,no,no,no,2.75,2.25,2.5,1.5,2.25,11.25,moderate,0.0,0.5,0.0,0.5,2.0,3.0,III,intermediate,Neocortical type,severe,SRR1568399,male
299,sample_SAMPLE_0835_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0835_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0835_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0835 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,6789965,6901184,0.983884,EXR-KJENS10CSF0835-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0835_CONTROL_CSF_fastq,08_35_CSF,3/4,87,,2.25,no,no,no,3.0,3.0,3.0,2.0,3.0,14.0,moderate,0.0,0.5,0.0,3.0,3.0,6.5,IV,criteria not met,No Lewy bodies,mild,SRR1568559,male
300,sample_SAMPLE_0205_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0205_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0205_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0205 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1120883,1524608,0.735194,EXR-KJENS10SER0205-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0205_PD_SER_fastq,02_05_SER,3/3,86,7.0,2.5,no,no,no,2.0,1.5,1.5,0.0,1.25,6.25,moderate,0.0,1.0,0.0,1.5,2.5,5.0,III,intermediate,Limbic type,severe,SRR1568396,male
301,sample_SAMPLE_0720_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0720_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0720_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0720 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,2541428,2726949,0.931968,EXR-KJENS10CSF0720-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0720_AD_CSF_fastq,07_20_CSF,3/3,57,10.0,2.16,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,No Lewy bodies,mild,SRR1568529,female
302,sample_SAMPLE_0832_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0832_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0832_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0832 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,7944691,8056349,0.98614,EXR-KJENS10CSF0832-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0832_PD_CSF_fastq,08_32_CSF,3/4,76,20.0,3.33,no,no,no,2.0,2.0,2.5,0.5,2.0,9.0,moderate,0.0,0.0,0.0,1.5,2.0,3.5,III,intermediate,Limbic type,severe,SRR1568558,male
303,sample_SAMPLE_9737_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9737_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9737_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9737 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,318974,329484,0.968102,EXR-KJENS10CSF9737-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9737_CONTROL_CSF_fastq,97_37_CSF,3/4,83,,3.16,no,no,no,0.0,0.5,0.5,0.0,0.0,1.0,zero,0.0,0.0,0.0,0.0,1.0,1.0,I,criteria not met,No Lewy bodies,none,SRR1568670,male
304,sample_SAMPLE_0865_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0865_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0865_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0865 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,12912508,13024065,0.991435,EXR-KJENS10SER0865-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0865_PD_SER_fastq,08_65_SER,2/3,74,17.0,8.75,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,1.5,1.5,3.0,III,criteria not met,Limbic type,severe,SRR1568572,male
305,sample_SAMPLE_9923_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9923_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9923_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9923 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,1331713,1353918,0.983599,EXR-KJENS10CSF9923-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9923_PD_CSF_fastq,99_23_CSF,3/3,89,,3.66,no,no,no,3.0,2.75,3.0,1.5,2.0,12.25,moderate,0.0,1.0,0.0,2.5,3.0,6.5,IV,criteria not met,Brainstem predominant type,,SRR1568726,female
306,sample_SAMPLE_9948_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9948_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9948_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9948 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,373031,431175,0.86515,EXR-KJENS10SER9948-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9948_AD_SER_fastq,99_48_SER,3/4,85,5.0,2.25,no,no,no,2.75,2.5,3.0,2.5,2.75,13.5,moderate,0.0,2.5,0.0,3.0,3.0,8.5,IV,intermediate,No Lewy bodies,none,SRR1568744,female
307,sample_SAMPLE_0322_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0322_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0322_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0322 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,5807182,5862648,0.990539,EXR-KJENS10CSF0322-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0322_PD_CSF_fastq,03_22_CSF,3/3,86,11.0,10.5,no,no,no,2.5,2.0,2.5,1.0,2.0,10.0,moderate,1.0,1.0,1.0,2.5,3.0,8.5,IV,criteria not met,Limbic type,severe,SRR1568424,female
308,sample_SAMPLE_9749_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9749_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9749_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9749 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,2812370,2901792,0.969184,EXR-KJENS10CSF9749-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9749_PD_CSF_fastq,97_49_CSF,3/4,88,0.0,3.66,no,no,no,1.5,2.0,2.5,0.0,0.5,6.5,moderate,0.5,0.0,0.0,1.0,1.0,2.5,I,intermediate,Neocortical type,severe,SRR1568679,male
309,sample_SAMPLE_0835_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0835_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0835_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0835 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,7307560,7370171,0.991505,EXR-KJENS10SER0835-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0835_CONTROL_SER_fastq,08_35_SER,3/4,87,,2.25,no,no,no,3.0,3.0,3.0,2.0,3.0,14.0,moderate,0.0,0.5,0.0,3.0,3.0,6.5,IV,criteria not met,No Lewy bodies,mild,SRR1568560,male
310,sample_SAMPLE_0424_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0424_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0424_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0424 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,6995691,7357960,0.950765,EXR-KJENS10CSF0424-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0424_AD_CSF_fastq,04_24_CSF,3/4,78,8.0,1.83,no,no,no,3.0,3.0,3.0,1.5,2.75,13.25,frequent,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,No Lewy bodies,none,SRR1568456,male
311,sample_SAMPLE_0510_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0510_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0510_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0510 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,FAIL,93704,105437,0.88872,EXR-KJENS10SER0510-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0510_CONTROL_SER_fastq,05_10_SER,3/3,91,,1.5,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,1.0,1.75,2.75,II,criteria not met,No Lewy bodies,none,SRR1568473,male
312,sample_SAMPLE_0526_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0526_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0526_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0526 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,2684225,2737918,0.980389,EXR-KJENS10CSF0526-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0526_PD_CSF_fastq,05_26_CSF,3/3,73,18.0,7.16,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,0.0,1.0,1.0,I,criteria not met,Limbic type,moderate,SRR1568486,male
313,sample_SAMPLE_9944_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9944_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9944_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9944 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,2597535,2624972,0.989548,EXR-KJENS10CSF9944-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9944_CONTROL_CSF_fastq,99_44_CSF,3/4,69,,2.16,no,no,no,1.5,1.5,2.0,1.0,1.5,7.5,sparse,0.0,0.0,0.0,0.0,0.0,0.0,I,criteria not met,No Lewy bodies,none,SRR1568741,male
314,sample_SAMPLE_0552_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0552_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0552_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0552 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,990451,1495410,0.662327,EXR-KJENS10SER0552-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0552_AD_SER_fastq,05_52_SER,3/3,70,4.0,2.66,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,No Lewy bodies,none,SRR1568490,female
315,sample_SAMPLE_0239_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0239_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0239_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0239 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,9307418,9429705,0.987032,EXR-KJENS10CSF0239-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0239_AD_CSF_fastq,02_39_CSF,3/4,75,10.0,3.0,no,no,no,3.0,3.0,3.0,2.0,3.0,14.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,V,high,No Lewy bodies,none,SRR1568406,male
316,sample_SAMPLE_9830_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9830_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9830_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9830 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,6548408,6637812,0.986531,EXR-KJENS10CSF9830-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9830_AD_CSF_fastq,98_30_CSF,3/4,86,5.0,2.5,no,no,no,2.75,2.5,3.0,2.5,2.5,13.25,frequent,1.0,2.0,1.5,1.5,2.75,8.75,V,high,No Lewy bodies,moderate,SRR1568704,female
317,sample_SAMPLE_0334_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0334_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0334_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0334 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,4048596,4136598,0.978726,EXR-KJENS10CSF0334-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0334_AD_CSF_fastq,03_34_CSF,3/4,88,3.0,3.25,no,no,no,2.5,2.5,3.0,1.5,2.25,11.75,moderate,1.0,2.0,1.0,2.25,2.75,9.0,IV,intermediate,No Lewy bodies,none,SRR1568436,female
318,sample_SAMPLE_9958_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9958_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_9958_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9958 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,324772,402801,0.806284,EXR-KJENS10SER9958-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9958_CONTROL_SER_fastq,99_58_SER,2/2,91,,2.5,no,no,no,0.0,0.0,1.0,0.0,0.0,1.0,sparse,0.0,0.0,0.0,1.5,2.5,4.0,III,criteria not met,No Lewy bodies,none,SRR1568750,female
319,sample_SAMPLE_0415_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0415_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0415_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0415 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,12038038,12201302,0.986619,EXR-KJENS10CSF0415-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0415_PD_CSF_fastq,04_15_CSF,3/4,89,,2.66,no,no,no,2.5,2.5,3.0,0.25,1.25,9.5,moderate,0.0,0.0,0.0,1.5,1.75,3.25,III,criteria not met,Brainstem predominant type,mild,SRR1568450,male
320,sample_SAMPLE_0652_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0652_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0652_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0652 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,13370508,13489122,0.991207,EXR-KJENS10CSF0652-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0652_AD_CSF_fastq,06_52_CSF,3/3,78,8.0,3.33,no,no,no,2.0,2.5,1.5,0.0,2.5,8.5,moderate,1.5,1.5,1.5,0.0,0.5,5.0,V,high,No Lewy bodies,severe,SRR1568514,female
321,sample_SAMPLE_1036_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_1036_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_1036_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,1036 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1438147,1462354,0.983447,EXR-KJENS10SER1036-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_1036_AD_SER_fastq,10_36_SER,3/3,90,,4.5,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,V,high,No Lewy bodies,mild,SRR1568623,male
322,sample_SAMPLE_0869_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0869_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0869_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0869 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,8148711,8302761,0.981446,EXR-KJENS10CSF0869-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0869_AD_CSF_fastq,08_69_CSF,3/4,86,17.0,3.5,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,2.0,3.0,2.5,3.0,3.0,13.5,V,high,No Lewy bodies,moderate,SRR1568573,female
323,sample_SAMPLE_0764_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0764_AD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0764_AD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0764 Alzheimer's disease CSF,Alzheimer's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,653027,663651,0.983992,EXR-KJENS10CSF0764-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0764_AD_CSF_fastq,07_64_CSF,2/3,91,19.0,7.0,no,no,no,2.0,2.0,2.5,0.0,0.0,6.5,moderate,0.0,0.0,0.0,0.0,2.5,2.5,II,low,No Lewy bodies,mild,SRR1568546,female
324,sample_SAMPLE_0124_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0124_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0124_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0124 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2112641,2265778,0.932413,EXR-KJENS10SER0124-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0124_PD_SER_fastq,01_24_SER,3/4,75,8.0,4.5,no,no,no,2.5,2.5,3.0,1.0,1.75,10.75,moderate,0.0,0.0,0.0,0.25,1.75,2.0,II,intermediate,Limbic type,severe,SRR1568375,male
325,sample_SAMPLE_1039_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_1039_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_1039_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,1039 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2110684,2155962,0.978999,EXR-KJENS10SER1039-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_1039_CONTROL_SER_fastq,10_39_SER,3/3,93,,3.0,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,0.5,0.5,1.0,I,not AD,No Lewy bodies,none,SRR1568627,male
326,sample_SAMPLE_0201_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0201_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0201_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0201 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,15016028,15441755,0.97243,EXR-KJENS10CSF0201-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0201_CONTROL_CSF_fastq,02_01_CSF,3/3,88,1.0,3.0,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.5,0.0,2.0,2.0,4.5,IV,criteria not met,No Lewy bodies,mild,SRR1568391,female
327,sample_SAMPLE_0201_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0201_CONTROL_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0201_CONTROL_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0201 Healthy Control CSF,Healthy Control,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,15016028,15441755,0.97243,EXR-KJENS10CSF0201-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0201_CONTROL_CSF_fastq,02_01_CSF,3/4,88,1.0,2.0,no,no,no,1.5,1.5,2.0,0.0,1.25,6.25,moderate,0.0,0.0,0.0,0.5,2.0,2.5,III,criteria not met,No Lewy bodies,none,SRR1568391,female
328,sample_SAMPLE_0874_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0874_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0874_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0874 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2307242,2349814,0.981883,EXR-KJENS10SER0874-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0874_PD_SER_fastq,08_74_SER,3/3,79,,3.16,no,no,no,1.5,2.0,1.5,0.0,2.5,7.5,sparse,0.0,0.5,0.0,1.0,2.0,3.5,II,criteria not met,Limbic type,severe,SRR1568577,female
329,sample_SAMPLE_0127_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0127_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0127_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0127 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,6357074,6556341,0.969607,EXR-KJENS10SER0127-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0127_PD_SER_fastq,01_27_SER,2/4,72,9.0,3.0,no,no,no,2.0,1.75,2.5,0.0,0.75,7.0,moderate,0.0,0.0,0.0,0.25,0.25,0.5,I,intermediate,Limbic type,severe,SRR1568377,male
330,sample_SAMPLE_0877_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0877_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_0877_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0877 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2976286,3008149,0.989408,EXR-KJENS10SER0877-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0877_CONTROL_SER_fastq,08_77_SER,3/3,91,,7.25,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,2.0,2.0,4.0,IV,criteria not met,No Lewy bodies,none,SRR1568579,female
331,sample_SAMPLE_0334_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0334_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0334_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0334 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2058072,2117362,0.971998,EXR-KJENS10SER0334-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0334_AD_SER_fastq,03_34_SER,3/4,88,3.0,3.25,no,no,no,2.5,2.5,3.0,1.5,2.25,11.75,moderate,1.0,2.0,1.0,2.25,2.75,9.0,IV,intermediate,No Lewy bodies,none,SRR1568437,female
332,sample_SAMPLE_0316_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0316_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0316_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0316 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,2734386,3002151,0.910809,EXR-KJENS10SER0316-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0316_PD_SER_fastq,03_16_SER,2/3,82,13.0,3.25,no,yes,no,2.5,2.0,2.5,0.0,1.75,8.75,moderate,0.0,0.0,0.0,0.25,0.75,1.0,II,intermediate,Neocortical type,severe,SRR1568419,male
333,sample_SAMPLE_9725_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9725_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9725_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9725 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,9071965,9211671,0.984834,EXR-KJENS10SER9725-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9725_AD_SER_fastq,97_25_SER,3/3,84,5.0,2.15,no,no,no,3.0,3.0,3.0,2.0,2.0,13.0,frequent,1.5,2.0,1.5,3.0,2.5,10.5,V,high,No Lewy bodies,none,SRR1568669,female
334,sample_SAMPLE_9824_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9824_PD_SER_fastq/CORE_RESULTS/sample_SAMPLE_9824_PD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9824 Parkinson's Disease SER,Parkinson's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1266023,2358081,0.536887,EXR-KJENS10SER9824-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9824_PD_SER_fastq,98_24_SER,2/3,81,8.0,2.5,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.0,0.0,1.5,1.0,2.5,I,criteria not met,Neocortical type,moderate,SRR1568701,male
335,sample_SAMPLE_9938_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9938_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9938_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9938 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,4254676,4316414,0.985697,EXR-KJENS10CSF9938-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9938_PD_CSF_fastq,99_38_CSF,3/3,78,23.0,1.75,no,no,no,0.0,0.0,0.0,0.0,0.0,0.0,zero,0.0,0.5,0.0,2.5,2.5,5.5,III,criteria not met,Limbic type,severe,SRR1568738,female
336,sample_SAMPLE_0612_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0612_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0612_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0612 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,FAIL,419041,1486169,0.281961,EXR-KJENS10SER0612-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0612_AD_SER_fastq,06_12_SER,3/4,74,8.0,4.0,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,VI,high,No Lewy bodies,mild,SRR1568496,female
337,sample_SAMPLE_1022_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_1022_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_1022_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,1022 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,14354010,14584449,0.9842,EXR-KJENS10SER1022-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_1022_CONTROL_SER_fastq,10_22_SER,3/3,59,,3.15,no,no,no,0.0,1.0,0.0,0.0,0.5,1.5,zero,0.0,0.0,0.0,0.0,0.5,0.5,I,criteria not met,No Lewy bodies,none,SRR1568613,female
338,sample_SAMPLE_0427_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0427_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0427_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0427 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,11273711,11415638,0.987567,EXR-KJENS10CSF0427-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0427_PD_CSF_fastq,04_27_CSF,3/4,79,20.0,3.5,no,no,no,2.5,3.0,3.0,2.0,2.75,13.25,moderate,0.5,0.5,0.5,2.0,3.0,6.5,IV,intermediate,Neocortical type,severe,SRR1568457,female
339,sample_SAMPLE_9635_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9635_CONTROL_SER_fastq/CORE_RESULTS/sample_SAMPLE_9635_CONTROL_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9635 Healthy Control SER,Healthy Control,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1605412,1873314,0.85699,EXR-KJENS10SER9635-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9635_CONTROL_SER_fastq,96_35_SER,2/3,84,,2.66,no,no,no,1.5,1.5,1.5,1.5,1.0,7.0,sparse,0.0,1.0,1.0,1.0,1.0,4.0,III,criteria not met,No Lewy bodies,none,SRR1568654,male
340,sample_SAMPLE_9926_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_9926_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_9926_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,9926 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,4493606,4541388,0.989479,EXR-KJENS10CSF9926-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_9926_PD_CSF_fastq,99_26_CSF,3/3,79,1.0,6.0,no,no,no,0.0,1.75,1.0,0.0,0.0,2.75,sparse,0.0,0.75,0.0,1.5,1.0,3.25,II,criteria not met,Limbic type,severe,SRR1568729,female
341,sample_SAMPLE_0329_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0329_PD_CSF_fastq/CORE_RESULTS/sample_SAMPLE_0329_PD_CSF_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0329 Parkinson's Disease CSF,Parkinson's Disease,Cerebrospinal fluid,total cell-free biofluid RNA,MiRVana Paris (Ambion),Brain ventricle structure,Not Applicable,small RNA-Seq,Human,PASS,3319130,3355949,0.989029,EXR-KJENS10CSF0329-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0329_PD_CSF_fastq,03_29_CSF,2/3,79,23.0,4.5,no,no,no,0.25,0.0,0.0,0.0,0.0,0.25,zero,0.0,0.0,0.0,0.5,1.25,1.75,II,criteria not met,Limbic type,severe,SRR1568430,male
342,sample_SAMPLE_0702_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,ftp://ftp.genboree.org/exRNA-atlas/grp/Extracellular%20RNA%20Atlas/db/exRNA%20Repository%20-%20hg19/file/exRNA-atlas/exceRptPipeline_v4.6.2/KJENS1-Alzheimers_Parkinsons-2016-10-17/sample_SAMPLE_0702_AD_SER_fastq/CORE_RESULTS/sample_SAMPLE_0702_AD_SER_fastq_KJENS1-Alzheimers_Parkinsons-2016-10-17_CORE_RESULTS_v4.6.2.tgz,0702 Alzheimer's disease SER,Alzheimer's Disease,Serum,total cell-free biofluid RNA,MiRVana Paris (Ambion),Entire cardiovascular system,Not Applicable,small RNA-Seq,Human,PASS,1512329,2082983,0.72604,EXR-KJENS10SER0702-BS,EXR-KJENS1sPlvS2-AN,sample_SAMPLE_0702_AD_SER_fastq,07_02_SER,3/3,87,5.0,3.0,no,no,no,3.0,3.0,3.0,3.0,3.0,15.0,frequent,3.0,3.0,3.0,3.0,3.0,15.0,V,high,No Lewy bodies,mild,SRR1568523,female
